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      1. Introduction 
1.1. Definition 
Atrioventricular septal defects are congenital heart diseases in which the septal tissue  
immediately above and below the normal level of the AV valves is deficient or absent. 
In all forms of atrioventricular septal defects there are abnormal AV valves to a varying 
degree. They have been also called endocardial cushion defects due to developmental 
disturbance in endocardial cushion, AV canal defects, ostium primum defects (when 
there is no VSD), and common AV valve (when there is only a single AV valve orifice)  
(1). 
 
     1.2. Etiology 
During fetal life between 3-8 weeks, the embryologic abnormality in AV septal defects is 
disturbance of the proper development of the endocardial cushions, which are 
responsible for the septation of the atria and ventricles (membranous portion). But the 
exact causes are unknown (2). 
 
     1.3. History background  
 Abbot  first recognized ostium primum ASD and common AV canal defect (3), but their 
morphologic similarity was recognized by Rogers and Edwards in 1948 (4). The terms 
partial and complete atrioventricular canal defects were introduced by Wakai and 
Edwards in 1956 and 1958 (5;6). The description of the position of the AV node and 
bundle of His, and the concept of ostium primum ASD (partial AV canal) and common 
AV orifice (complete AV canal) was done by Lev (7). The term intermediate and 
transitional was added by Wakai and Edwards and later by Bharati and Lev (8). Van 
Mierops studies added a great deal of knowledge to the overall anatomic features of AV 
septal defects during this periods (9). In 1966, Rastelli and colleagues described the 
morphology of AV valve leaflets in cases with common AV orifice (10). In 1976 the 
concept of leaflets bridging the ventricular septum introduced by Ugarte and colleagues, 
which was also used by Lev (11). In the late 1960s, based on anatomy and 
cineangiography and the description by Baron and colleagues and Van Mierop and 
colleagues, it was recognized that the basic defect was absence of AV septum, which can 
be imaged by echocardiography and in cineangiography in the right anterior oblique 
projection (12). These concepts were further expanded by Picoli and colleagues, and then 
R.H. Anderson who emphasized that  all variations  were part of a spectrum (13). Dennis 
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and Varco, in 1952 used a pump- oxygenator to close what they thought ASD. The 
patient died, and the autopsy showed that it was partial AV septal defect. The first 
successful repair of a complete AV septal defect was done by Lillehei and colleagues in 
1954, by using cross circulation and direct suture of the atrial rim of the defect to 
ventricular septal crest (14). In 1955, Kirklin and colleagues closed partial AV septal 
defect by open cardiotomy and use of the pump- oxygenator (15). Early mortality rates 
for repair were 50%. The most common complications were complete heart block, mitral 
valve regurgitation and creation of subaortic stenosis (16). After delineation the bundle 
of His by Lev in 1958, the incidence of heart block reduced. The improved 
understanding of the structure and function of the common AV valve and the improved 
surgical techniques and cardiopulmonary bypass and a realization of the importance to 
close the mitral valve cleft without inducing stenosis lead to decreased short- and long- 
term incidence of mitral regurgitation with low morbidity and mortality rates. The single- 
patch technique was first described by Maloney and colleagues and later on by Gerbode 
in 1962 (17). The two- patch technique was described early by Dubost and Blondeau in 
1959 (18). 
 
1.4. Epidemiology 
Seven to 8 babies per 1000 live births have congenital heart disease, and this accounts 
for 3% of all infant deaths and 46% of deaths due to congenital malformations. Around 
18- 25% of affected infants die in the first year with 4% of those surviving infancy dying 
by 16 years (Dezateux et al. (19)). Atrioventricular septal defects represent 
approximately 4% of all congenital cardiac anomalies, and they are frequently associated 
with other cardiac malformations, especially patients with Down syndrome. Complete 
AVSD is frequently (60%-86%) associated with Down syndrome (20;21). 
 
1.5. Anatomy and Associated cardiac anomalies 
1.5.1. General morphologic anatomy 
The deficiency or absence of AV septum above the AV valves results in an ostium primum 
defect and below the AV valves it results in a deficiency of the basal (inlet) portion of the 
ventricular septum. The patients with partial AV septal defects have ostium primum ASD 
and some deficiency in the basal (inlet) portion of the ventricular septum which is less than 
in patients with complete AV septal defects (22). The septal deficiency may or may not 
result in interatrial or interventricular communications, depending on attachments of the 
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AV valves. From the clinical point of view, there are partial, intermediate, and complete 
forms of AV septal defects. In the partial form, there exists an ostium primum ASD. Here 
the AV valves are attached to the crest of the interventricular septum, and there is usually 
no interventricular communication. The anterior leaflet of the mitral valve is considered to 
form part of a trileaflet mitral valve, because it has a cleft of varying degree. On occasion, 
this mitral valve may have some degree of incompetence, but most commonly, it is 
competent. In the intermediate form, the main distinguishing feature from partial AV septal 
defects is the incomplete attachement of the AV valves to the interventricular septum. So 
that some gaps may exist and some degrees of underdevelopment of the leaflet tissues may 
be present. In the complete AV septal defect, both the lower atrial and inlet (basal) 
ventricular septum are deficient or absent. The attachment and configuration of the AV 
valves to the ventricular septum are quite variable. 
There is often variability in the number of leaflets, but usually five or more AV valves 
leaflets of variable size are present. There may be one (common) or two AV valve orifices. 
For left AV valve there is left superior leaflet (LSL), left inferior leaflet (LIL) and left 
lateral leaflet (LLL). For right AV valve there is right superior leaflet (RSL), right inferior 
leaflet (RIL) and right lateral leaflet (RLL) (Figure 1). 
The ratio of anterior leaflet to posterior leaflet of the left AV valve in patients with AV 
septal defect is reversed to normal, this means that the posterior (left lateral) leaflet 
contributes to one- third (1/3) and the bileaflets anterior cusp (the left superior and inferior 
leaflets together) contributes to two- thirds (2/3) of the mitral valve annulus (Figure 2). 
The hearts with AV septal defects are characterized by absence of the usual wedged 
position of the aortic valve in relation to both AV valves in normal hearts. This is due to 
down displacement toward the apex of AV valves because of deficiency of the inlet portion 
of the septum, so that aortic valve is elevated and displaced anteriorly (9). In addition, the 
left ventricular outflow tract is narrowed and elongated, although rarely sufficient to be of 
hemodynamic importance in the unrepaired heart, while the LV inflow tract is shortened 
(13). The AV node is displaced posteriorly and inferiorly toward the coronary sinus, so that 
it lies between it and the ventricular crest, in the nodal triangle (Koch triangle), which is 
bounded by the coronary sinus, the rim of the ASD, and the posterior attachment of the 
inferior bridging leaflet. The bundle of His courses antero- superiorly to run along the 
leftward aspect of the crest of the VSD, giving off the left bundle and continuing as the 
right bundle branch (7) (Figure 3). 
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Figure 1: Mitral- tricuspid valve relationship. A: In the normal heart. B: Partial 
atrioventricular septal defect. C: Complete atrioventricular septal defect. (Modified 
from Khonsari (23)). 
 
 
 
Figure 2: Mitral valve annular configuration. A. In the normal mitral valve. B. In 
an atrioventricular septal defect mitral valve. (Modified from Khonsari (23)). 
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     Figure 3: Sketch of the course AV node and His bundle. (Modified from Lev (7)).            
     Key: ●, AV node; ▲, penetrating portion of the AV bundle; ●▬, branching of the AV bundle; ▬ , right   
        bundle branch; 1, SVC; 2, IVC; 3, limbus; 4, PFO; 5, cut edge of atrial appendage; 6, coronary sinus; 8, AV  
        septal communication; 9, infundibulum; 10, base of pulmonary valve; 11, muscle of Lancisi; 12, cut edge of 
        moderator band. 
 
1.5.2. Partial atrioventricular septal defect 
There is usually ostium primum ASD of moderate size which is bounded superiorly by a 
crescentic ridge of atrial septum that fuses with the AV valve annulus inferiorly only at its 
margins (Figure 4). This defect is characterized by presence of two AV valves, in which the 
mitral valve has a cleft between the left superior and left inferior leaflets and are joined to a 
variable extent anteriorly by leaflet tissue near the crest of the ventricular septum, so that it 
is a tricuspid valve in contrast to a normal valve. In most cases there is also a patent 
foramen ovale or ostium secundum ASD. The interatrial communication may be small in 
size and is restricted to the area normally occupied by the atrioventricular septum or 
because of the fusion of the base of the left superior or inferior leaflets to the edge of the 
adjacent atrial septum (24). Rarely, AV valve tissue is attached completely to the edge of 
the atrial septum, and no interatrial communication exists despite the deficiency in the 
septum (13;25). In unusual variants of partial AV septal defect some degree of deficiency 
of the inlet portion of  the ventricular septum may be found, especially when the inlet 
portion is shortened and this leads to interventricular communication, but when the left 
superior and inferior leaflets are attached to the downward displaced septal crest, there is 
usually no interventricular communication. Occasionally there are one or more small 
interventricular communications beneath the AV valve. 
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Figure 4: Partial atrioventricular septal defect. (Modified from Khonsari (23)). 
Key: RS, RL, and RI, are right superior, right lateral, and right inferior leaflets respectively. LS, LL, and LI, 
are left superior, left lateral, and left inferior leaflets respectively.  
 
 
1.5.3. Complete atrioventricular septal defect 
Characterized by moderate to large interventricular communications, and common AV 
valve in which the left superior and left inferior leaflets are usually separated (Figure 5). 
The deficiency in inlet portion of the ventricular septum is usually more than in partial AV 
septal defect. The interventricular communication is large beneath left superior leaflet and 
smaller or none beneath left inferior leaflet. Very rare, there is no VSD beneath the left 
superior leaflet and a large one beneath left inferior leaflet (26;27).  
Chordal attachments of the common AV valve in the LV are usually relatively normal, but 
displaced toward the apex of the heart due to deficiency of the inlet portion of the septum, 
this leads to no longer aortic valve between the AV valves (28-30). In LV a third papillary 
muscle may be present and the posterior papillary muscle is displaced laterally. There may 
be only one papillary muscle which is producing a parachute type valve that is difficult to 
repair. Rarely, the left AV valve is stenotic, but this is usually associated with hypoplasia 
of the LV (31). The right AV valve has also superior, inferior, and lateral leaflets. The right 
superior leaflet is small when the left superior leaflet bridging is extensive and large when 
the left superior leaflet bridging is mild or absent. 
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Figure 5: Complete atrioventricular septal defect. (Modified from Khonsari (23)). 
Key: RS, RL, RI are right right superior, right lateral, and right inferior leaflets, respectively. LS, LL, LI are 
left superior, left lateral, and left inferior leaflets, respectively. 
 
 
1.5.4. Rastelli classification 
This classification based on whether the left superior leaflet bridges or not over the septal 
crest to the right ventricular side. It essentially focuses on the shape, size, location and 
details of the attachments of the left superior leaflet. 
In type A, which is very often seen, the left superior leaflet is over the left ventricle and its 
chordal attachment is to the crest of the ventricular septal defect. 
In type B, which is rarely seen, the chordal attachment of the left superior leaflet is to an 
abnormally located papillary muscle on the right ventricular aspect of the interventricular 
septum. 
In type C, which is seen quite often, the left superior leaflet is large and bridges the 
ventricular septal defect and right ventricle and its chordal attachement are variable (10) 
(Figure 6). 
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 Figure 6: Atrioventricular valves viewed from atrial side. A. Normal mitral and 
tricuspid valves. B. Leaflets in partial atrioventricular septal defects. C. Rastelli´s 
classification of complete atrioventricular septal defects. (Modified from Kirklin/ 
Barratt-Boyes (32)). 
 
1.5.5. Associated cardiac anomalies 
Patent ductus arteriosus is present in about 10% of cases especially in complete AV septal 
defects. Tetralogy of Fallot is present in about 5% of patients with AV septal defects. 
Double outlet right ventricle without pulmonary stenosis is found in about 2% of patients. 
Completely unroofed coronary sinus with left superior vena cava is found in 3% of cases of 
the complete AV septal defects and 3% of cases of the partial AV septal defects (25). 
Pulmonary vascular disease is common in complete AV septal defect and usually appears 
early in life and progresses. Down syndrome is found in 75% of cases with complete AV 
septal defect, but is rare in cases with partial AV septal defects. Left ventricular outflow 
tract obstruction is rare in unoperated patients (about 1%) (25), but it becomes apparent as 
a postoperative complication (33). 
 
1.6. Pathophysiology, Natural history and Diagnostic methods 
1.6.1. Pathophysiology 
Unless severe pulmonary hypertension or associated pulmonary stenosis, there is usually 
left to right shunt. In partial AV septal defect, it is at the atrial level and usually large, but 
sometimes it is small or moderate. If the shunt is large, and there is no AV valve 
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regurgitation, then it is hemodynamically similar to ASD of the secundum type, and only 
the RV stroke volume is increased. In case of important left AV valve regurgitation, the left 
to right shunt will be more, and the stroke volume of both LV and RV will be increased, 
and cardiomegaly and heart failure develop early. In case of complete AV septal defect, the 
left to right shunt is both at atrial and ventricular level and pulmonary artery pressure 
approaches the systemic pressure and if not corrected early the pulmonary resistance will 
be fixed and the risk of repair is increased (34). 
 
1.6.2. Natural history 
The natural history depends mostly on the extent of the three components of the septal 
defects; atrial shunt, ventricular shunt, and the AV valve regurgitation. In complete AV 
septal defects they usually are presented early in life with severe heart failure with or 
without pulmonary infections, which is complicated if it is associated with Down 
syndrome, because of the early tendency to develop fixed pulmonary vascular resistance. In 
the other end of the spectrum, the partial AV septal defect, the prognosis depends on the 
extend of shunt volume and AV valve regurgitation. The patients are usually asymptomatic 
and presented later in childhood or young adulthood. By complete AV septal defects the 
mean life expectancy by some patients is less than 6 months or even less in patients with a 
fixed pulmonary vascular resistance who developing symptoms of Eisenmenger- reaction 
(right to left shunt). 
 
1.6.3. Diagnostic methods 
The exact diagnosis of AVSD can be made with two- dimensional echocardiography (35). 
Clinical presentation, chest radiograph, and electrocardiogram let suspect AVSD (36). The 
need for cardiac catheterization is not necessary before 6 months of age because the 
probability to develop fixed high pulmonary resistance is low, but it can be used when 
major cardiac anomalies coexist or evidence of pulmonary vascular disease or the 
echocardiographic examinations are not clear (29).  
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2. Therapy options 
2.1. Medical therapy 
Patients with partial AV septal defects present with signs and symptoms similar to those of 
secundum ASD´s and as such, they rarely need medical therapy. In patients with complete 
AV septal defects, medical therapy consists of anticongestive treatment for the signs and 
symptoms of congestive heart failure. The mainstays of medical therapy are Diuretics (for 
diuresis for the volume overloaded heart), digoxin (as a mild inotrope), and ACE- 
inhibitors (for afterload reduction), as reported by Montigny et al. (37). In our institution 
low dose B- blockers are successfully used due to blocking the sympathetic activity and by 
reducing  systemic vascular resistance without decreasing blood pressure which is also 
described by Buchhorn et al. (38). 
 
2.2. Surgical therapy 
2.2.1. Surgical indications 
The diagnosis of an AV septal defect is in principle an operation indication, because 
spontaneous closure does not occur and the hemodynamic derangement is nearly always 
present. By partial AV septal defect the optimal age for operation is 1 to 2 years, but this 
could be earlier if there is AV valve regurgitation, heart failure or severe growth failure. 
In complete AV septal defect, operation is indicated early in the first year of life, usually 
before 6 months of age, but if refractory heart failure or severe growth failure is evident 
early, then repair at 2 to 4 months of age is indicated. Operation after the first year of age is 
associated with increased risk,  because the pulmonary vascular disease may be already too 
severe to permit repair. 
 
2.2.2. Aims of  surgical repair 
1- Closing the interatrial communication, which is always present. 
2- Closing the interventricular communication, when one is present. 
3- Creating, or maintaining two competent, nonstenotic AV valves. 
4- Avoiding AV block induction by damage to the AV node and or His bundle. 
      For these purposes there are many repair techniques, which, when used properly,  
      provide good results (39;40), for example: 
a. One or two patches may be used to repair the malformation when there is a large VSD 
(41). 
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b. A large bridging left superior leaflet, may be divided to facilitate the repair or left intact 
(25;42;43). 
c. Damage to AV node and His bundle may be avoided by staying on the right side of the 
septum (25). 
d. The cleft between the LSL and LIL, may be sutured or may be left as tricuspid valve to 
avoid valve stenosis (44;45). 
e. The AV valves may be attached to the patch by simple or by pledgeted mattress sutures 
with some sort of sandwich method, to establish AV valve competence (25;44). 
 
2.2.3. Surgical techniques 
2.2.3.1. Two-  patch technique for complete AVSD repair 
After a median sternotomy, a piece of pericardium is taken and cleared from pleural fat, 
and set aside in 0.6% glutaraldehyde, after the remaining pericard is widely opened, stay 
sutures are placed and the anatomy is examined. The patient is heparinized and arterial 
cannula inserted. Two venous cannulae are used, one inserted through the right atrial 
appendage in the SVC, the other through the low right atrial wall in IVC. Direct caval 
cannulation can be done also. CPB is established with 34°C cold perfusate, and the patient 
cold to 31°C. The cardioplegic needle is now placed in the ascending aorta, the aorta is 
clamped, and the cold cardioplegic solution is infused. The caval tapes are snugged. 
After that the right atrium is opened, the malformation is examined and each morphologic 
details are noted.  Valve leaflets are often closed as they are in systole. If not, saline is 
injected into LV to close them, then the morphology of the leaflets is studied to plan the 
repair of any regurgitation or to accommodate any lack of left AV valve tissue. A fine 
polypropylene suture is placed between LSL and LIL and left loose. The leaflets are 
allowed to open and atrial and ventricular septal defects are studied. Position of coronary 
sinus is noted, and the course of AV node and His bundle is imaginated from knowledge of 
the anatomy. The leaflets are retracted and the depth of the ventricular septal defect 
estimated. Dacron patch is trimmed to a crescent shape of appropriate size. Suture line may 
begin anywhere, but it must be on the right ventricular side of all chordae from left side 
leaflets, including those from any bridging components of the LIL. Suture line should stay 
well back from ventricular crest and catch some of the base of the RIL to avoid His bundle 
injury. Suture line is completed anteriorly, here care must be taken to avoid LVOTO. The 
LSL and LIL are precisely fixed to the patch by using interrupted simple or mattress 
sutures. Here care must be taken to ensure that the mitral valve apparatus at the patch is 
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appropriately narrow so as not to create regurgitation and at the correct height so as not to 
produce LVOTO (too low) or mitral regurgitation (too high). Mitral valve cleft is closed by 
interrupted simple sutures, testing mitral valve for competence. The RSL and RIL are fixed 
to the Dacron patch, and any cleft closed also. The pericardial patch is trimmed to size the 
atrial defect, and a new suture line is begun with bites incorporating pericardial patch, the 
right AV valve, the Dacron patch and little fom left AV valve. The pericardial patch is 
sutured anteriorly, superiorly, and inferiorly by leaving coronary sinus draining into left 
atrium to avoid conduction system injury (Figure 7: A- D). After that rewarming is carried 
out, right atrium closed, the heart is filled, and the aortic cross clamp is removed after 
deairing procedures are performed. Then operation assessment is performed by 
transesophageal echocardiography. 
 
 
 
Figure 7- A: The common AV valve is floated to a closed position using saline 
solution. The central apposition points of the superior and inferior bridging leaflets 
are identified and marked with fine polypropylene. (Modified from Ohye (46)). 
 
 
 
 
Figure 7- B: Two-patch technique. A patch of Goretex or Dacron is fashioned and 
secured along the crest of the ventricular septal defect. (Modified from Ohye (46)). 
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Figure 7- C: Two-patch technique. Interrupted horizontal mattress sutures are 
placed through the crest of the VSD patch and the inferior and superior bridging 
leaflet, dividing the common AV valve into right and left components. (Modified 
from Ohye (46)). 
 
 
 
Figure 7- D: The pericardial patch is sutured to the crest of the prosthetic 
ventricular septum with the superior and inferior bridging leaflet sandwiched 
between the 2 patches. (Modified from Ohye (46)). 
 
2.2.3.2. Single- patch technique for complete AVSD repair 
Repairing differs from 2- patch technique in the following:  
1. Single patch almost always pericardium. 
2. The waist tailoring at the level of AV valve is critical. 
3. Both left and right AV valves are sutured to the pericardial patch. 
The preparation for bypass is the same as for two- patch technique. After aortic cross 
clamping and cardioplegic infusion, oblique right atriotomy is done, identifying the most 
anterior point of LSL and LIL, and 6-0 Prolene suture is placed and left loose, then the AV 
valve is tested by saline infusion. The bridging LSL and LIL is incised to allow access for 
suturing the pericardial patch (after trimming) to ventricular septal defect, to be later fixed 
again in the patch. The patch sutured on the right side of the septum, with care taken, to 
avoid injury to His bundle. The leaflets of both right and left AV valve are attached to the 
patch at its waist. The AV valve clefts are closed with interrupted simple suture and tested 
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with saline for competence. The same patch is also used to close the atrial septal defect, 
leaving the coronary sinus draining into the left atrium, in the same way as in two- patch 
technique (Figure 8: A- D).  
After that rewarming, right atriotomy closure, deairing and aortic cross clamp removed. 
Then operation assessment by transesophageal echocardiography, if  severe abnormalities 
are present, they should be corrected. Then the operation is completed in the usual manner 
after placing pulmonary artery catheter. 
 
 
 
 
 
 
Figure 8- A: Single- patch technique. The superior and inferior bridging leaflets 
are divided into right and left component. (Modified from Ohye (46)). 
 
 
 
 
Figure 8- B: The leaflets are resuspended to the patch by passing sutures through 
the cut edge of the AV valve leaflet, the patch, and the cut edge of the right AV valve 
and tying the sutures. (Modified from Ohye (46)). 
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 Figure 8- C: The cleft of the mitral valve between the superior and inferior 
bridging leaflets is closed. (Modified from Ohye (46)). 
 
 
 
Figure 8- D: The atrial septal defect is closed with an autologous pericardial patch. 
The coronary sinus is placed in the left atrium to avoid injury to the conduction 
system. The rim of the ASD, the AV node, the bundle of His are indicated. The 
dashes represent the proposed suture line. (Modified from Ohye (46)). 
 
2.2.3.3. Repair of partial AV septal defect 
It is a single patch repair in which the atrial septal defect is closed by a pericardial patch 
and the mitral valve cleft is closed at the thickened and rolled edges. The same precaution 
to avoid injury to AV node and His bundle is taken, by suturing the pericardial patch, so 
that the coronary sinus is draining to the left atrium, as in complete AV septal defect repair. 
The coronary sinus can be left draining to right atrium also. 
 
2.3. Aims of the study 
In our study we analyzed the records (data) of 110 patients with atrioventricular septal 
defects (74 patients with Down syndrome and 36 patients with normal chromosomal 
pattern), who underwent repair between January, 1997 and December, 2007. To evaluate 
the impact of different preoperative, operative, and postoperative factors on the outcome 
after repair of AVSD, we compared the patients with Down syndrome and non- Down 
syndrome in the early postoperative period and long- term course. 
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3. Patients and methods 
3.1. Study design 
Between January 1997 and December 2007, 130 patients were diagnosed with 
atrioventricular septal defects (partial and complete) in the Pediatric Heart Center, Giessen. 
From these 110 patients underwent two- patch and single- patch repair (biventricular 
repair), 20 patients were excluded, because 18 of them underwent univentricular correction 
repair (total cavopulmonary connection), and 2 underwent pulmonary artery banding, and 
were waiting for the final repair. These cohort included all patients undergoing two- patch 
and single- patch repair with and without palliative procedures, and also patients that 
underwent Fallot tetralogy repair. 
Institutional Review Board approval was obtained prior to study inclusion. Clinical 
preoperative patient characteristics, operative details and postoperative outcome data, 
including complications and mortality data were collected retrospectively.  
The patients (110) were divided into 2 groups, 74 patients (67.3%) presented with Down 
syndrome (group D) and 36 patients (32.7%) without Down syndrome (group ND). 
There were 58/110 females (52.7%) and 52/110 males (47.3%). A total of 100 patients    
(90.9%) had primary repair (one stage repair), 65 patients (87.8%) in group D and 35 
patients (97.2%) in group ND. The mean age at primary repair was 1.9 ± 3.6 years, while 
the median age was 7.2 months (range, 92 days- 19.8 years). A total of 40 patients             
(36.4%) were younger than 6 months at the primary repair, 33 patients in group D and 7 
patients in group ND. The median weight at repair was 5.82 kg (range, 3.35- 65 kg). A total 
of 3 patients (2.7%) underwent repair weighing less than 4 kg, 2 patients with Down 
syndrome and 1 patient without . The mean age at primary repair was 1.5 ± 3.5 years          
(median = 6.1 months) in group D and 2.6 ± 3.9 years (median = 14.5 months) in group 
ND. A total of 10 patients (9.1%) underwent palliative surgery 12 days to 6.9 years (mean 
= 0.9 ± 2.1 years, median = 3.7 months) before repair. There were 106 patients diagnosed 
as complete AV septal defects and 4 diagnosed as partial AV septal defects (Table 1). 
According to the intraoperatively assessed Rastelli classification: 84.5 % of the patients 
who underwent atrioventricular septal defect repair presented with type A, 10 % with type 
B, and 5.5 % presented with type C. Six of the patients who underwent primary repair had 
severe left side AV valve insufficiency, and 6 patients (5.5%) additionally associated with 
tetralogy of Fallot. Clinical follow- up was possible for 105 patients (96.3%) and the mean 
follow-up duration was 3.5 ± 3.2  years, range (13 days- 10.9 years) (Table 2). 
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     Table 1: Patients clinical characteristics 
 Total number (%) 
Complete AVSD 106/110 96.4 
 Partial AVSD 4/110 3.6 
Female 58/110 52.7  
Male 52/110 47.3 
Down syndrome (group D) 74 67.3 
Non- Down syndrome (group ND) 36 32.7 
 
      Table 2: Patients characteristics and follow- up (All patients) 
 Number (%) Mean SD Median Range 
Operation Age    1.9 y 3.6 y 7.18 m 3.1 m- 19.8 y  
Operation weight (kg)    9.3 kg 10.6 kg 5.82 kg 3.35- 65 kg 
Follow-up 105/109 96.33 3.5 y 3.2 y  2.5 y 13 d- 10.9 y 
 
 
3.2. Diagnosis 
All patients with AV septal defects are diagnosed or the diagnosis confirmed by two- 
dimensional echocardiography (100%) particularly with Doppler color flow imaging and 
when possible, with transthoracic window, M- mode. Cardiac catheterization was done for 
79 patients (71.8%) without anaesthesia in analgo- sedation and all were diagnostics. 
Direction and magnitude of shunting, pulmonary and systemic pressures, resistances and 
reversibility, if pulmonary vascular resistance was high, left and right ventricular pressures 
were measured. In addition to that, associated cardiac anomalies were confirmed or 
excluded. By all patients electrocardiography was done to check for cardiac rhythm, 
ventricular hypertrophy, PR- interval, QRS interval and vectorcardiogram. Chest 
radiography was done for all patients. Preoperatively all patients underwent screening for 
other congenital anomalies and metabolic diseases by newborn screening test. All patients 
underwent intraoperatively and postoperatively echocardiography examination (Table 3). 
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     Table 3: Diagnostic methods 
 Number (%) 
Echocardiography 110 100  
Cardiac catheterization 79 71.8 
Electrocardiography 110 100  
Chest radiography 110 100  
 
3.3. Anaesthesia and CPB 
Induction of anaesthesia was performed with desflurane®, remifentanil® or fentanyl® 
together with muscle relaxant (atracurium®), and maintenance of anaesthesia was done 
with continuous infusions associating fentanyl®, propofol® (in patients more than 1 year 
of age) and or midazolam®. A radial or femoral arterial line and central venous line were 
placed. All patients underwent the procedure with a closed circuit including gas exchanger 
and a roller pump. The efficacy of perfusion was assessed by continuous monitoring of the 
oxygen venous saturation which was kept over 70%, continuous hemoglobin level 
measurement and discontinuous blood gas analysis. Temperature was measured with rectal, 
esophageal and arterial line probes. CPB was performed at a flow rate 2,6 L/min./m² in the 
hypothermic phase (31-32°C), using pH-stat blood gas management with a PaO2 
maintained below 150 mmHg. The hematocrit is targeted to be at least 45% at the end of 
CPB. 
 
3.4. Operative techniques 
All procedures were performed by more than one surgeon, through median sternotomy. An 
autologous pericardial patch was harvested and kept moist in a cold saline after fixation in 
glutaraldehyde. CPB was established via standard aortic and bicaval venous cannulation. 
The left ventricle was decompressed by venting through the ASD or the patent foramen 
ovale after right atriotomy. Moderate hypohermia (31-32°C) and antegrade cold 
Bretschneider cardioplegia (30 ml/kg) were used for myocardial protection. Single- patch 
technique plus left AV valve cleft closure and or right AV valve repair was done in all 
patients with partial AV septal defects (n = 4). Two- patch technique or Single- patch 
technique plus AV valve repairs was done in all patients with complete AV septal defects 
(n = 106), this including the tetralogy of Fallot and persistent left superior vena cava 
patients. In some patients with complete AVSD, the VSD was closed by direct fixation of 
AV valve to the ventricular septal crest, or by a direct interrupted mattress suture                 
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(modified single- patch technique), or simply left because it was already almost closed or 
covered by septal leaflet of the tricuspid valve (right side AV valve). 
 
3.5. Follow- up 
 Follow- up data were obtained by review of clinical records, including echocardiography, 
cardiac catheterization and electrocardiography data. To assess the follow- up, all available 
clinical records at the Pediatric Heart Center, Giessen and clinical records from the local 
pediatric cardiologists are collected. Further telephone communications with the patients 
pediatricians and last polyclinic visit summary were gathered. The mean follow- up 
duration for all patients was 3.5 ± 3.2 years (range, 13 days- 10.9 years), and it was for 
96.3% (105/109) of patients complete.  
 
3.6. Statistical analysis 
All the data were analyzed using a commercial statistical software program. Data 
(continuous variables) are presented as mean ± standard deviation, or median with range  as 
appropriate. Binomial or ordinal data are expressed as percentages. Time- related changes 
in fredoom from re- operations and catheter- based intervention were estimated by using 
the Kaplan- Meier analysis (method). Time- related changes in survival estimation by using 
the Kaplan- Meier analysis was not used, because there was only 1 death. Statistical 
significance was reached when  p- value was < 0.05 by using un-paired student´s t- test. All 
data were analyzed with statistical computer programs “ WinSTAT and InSTAT”. 
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4. Results 
4.1. Preoperative data 
4.1.1. General patients characteristics  
From 110 patients who underwent AV septal repairs with two-patch and single- patch 
technique, 58 patients were females (52.73%), with 45.9% of the patients in group D 
(Down syndrome) and 66.7% in group ND (non- Down). The mean weight at repair was 
9.3 ± 10.6 kg, the median weight at repair was 5.82 kg (range, 3.35- 65 kg) for all patients. 
In group D, the mean weight was 8.1 ± 9.8 kg (median = 5.6 kg), and in group ND the 
mean weight was 11.8 ± 11.9 kg (median = 8.15 kg). The two- tailed p- value was not quite 
significant between the 2 groups (p = 0.0865). For all patients the median age at the 
operation was 7.2 months (range: 3.1 months – 19.8 years), and the mean age was 1.9 ± 3.6 
years. In group D the mean age was 1.5 ± 3.5 years (median = 6.1 months), while in group 
ND the mean age was 2.6 ± 3.9 years (median = 14.5 months). The two- tailed p- value was 
not significant between the 2 groups (p = 0.1393). From 110 patients, 106 were with 
complete AV septal defect (96.4%), and 4 patients (3.6%) were with partial AV septal 
defect, and by 55/110 patients (50%). In addition to ASD- I, there was also ASD- II or PFO 
in 50% of the patients in group D and also in 50% of the patients in group ND. According 
to Rastelli classification, type A was present in 93/110 of patients (84.5%), type B in 
11/110 of patients (10%) and type C in 6/110 of patients (5.5%). There was no difference 
between group D and ND. By 5/110 patients the diagnosis of AV septal defect was done 
prenatal (4.55%) by using echocardiography. The preterm babies were 13/110 patients 
(11.82%), there was no difference between group D and ND. The presenting signs and 
symptoms were; heart murmur in 100%, pulmonary hypertension in 69/110 (62.7%), 
sweating by drinking 55/110 (50%), failure to thrive 40/110 (36.4%), tachypnea and 
dyspnea 37/110 (33.6%), cyanosis 29/110 (26.4%), pallor 25/110 (22.7%), respiratory 
infection 24/110 (21.8%), edema 21/110 (19.1%), hypothyrosis 17/110 (15.5%), and 
epilepsy in 1/110 (0.91%). Preoperative incomplete and complete RBBB were diagnosed in 
38/110 patients (34.6%), and AV block grade I- II in 8/110 patients (7.3%). Only 1 patient 
had AV block grade II, Wenckebach type. The median preoperative oxygen saturation was 
96% (range,78-100%) and the mean was 95% ± 4.3. Only 1 patient (0.91%) was admitted 
to the hospital intubated from regional hospital because of pulmonary hypertensive crisis 
(Table 4 and 5). 
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     Table 4 : Preoperative data for all patients 
 Number  (%)   
cAVSD  106 96.4 
pAVSD 4 3.6 
ASD-II / PFO  55 50 
Rastelli- A 93 84.5 
Rastelli- B 11 10 
Rastelli- C 6 5.5 
Prenatal diagnosis 5 4.55 
Preterm babies 13 11.8 
Heart murmur  110 100 
Pulmonary hypertension 69 62.7 
Sweating  55 50 
Failure to thrive 40 36.36 
Tachypnea & dyspnea  37 33.64 
Cyanosis 29 26.36 
Pallor 25 22.73 
Respiratory infection 24 21.82 
Edema 21 19.09 
Hypothyrosis 17 15.45 
Epilepsy 1 0.91 
Incomplete RBBB & Complete RBBB 38 34.55 
AV block I- II 8 7.27 
Preoperative intubation 1 0.91 
  
     Table 5: Oxygen saturation preoperatively  
 Mean SD Median Range 
Oxygen saturation (%) 95 4.33 96 78- 100 
 
The total number of patients who presented with signs and symptoms of heart failure          
(sweating, tachypnea, dyspnea and edema) were 74 patients (67.3%). In group D, 56 
patients (75.7%) presented with pulmonary hypertension, 51 patients (68.9%) presented 
with symptoms and signs of congestive heart failure, and 20 patients (27%) presented with 
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respiratory infection. In group ND 13 patients (36.1%) presented with pulmonary 
hypertension, 23 patients (63.9%) with symptoms and signs of congestive heart failure, and 
4 patients (11.1%) with respiratory infection (Figure 9). The preoperative analysis of both 
groups revealed that patients in group D exhibited a significantly higher pulmonary 
pressure compared with patients in group ND. From the patients with Down syndrome (D 
group), 62 patients (83.8%) were Rastelli type A, 8 patients (10.8%) were Rastelli type B, 4 
patients (5.4%) were Rastelli type C, 5 patients with tetralogy of Fallot, and only 1 patient 
had preoperative severe mitral insufficiency grade (III) (Table 6). In group ND, 31 patients 
(86.1%) were Rastelli type A, 3 patients (8.3%) were Rastelli type B, 2 patients (5.6%) 
were Rastelli type C, 1 patient (2.8%) with tetralogy of Fallot, and 5 patients (13.9%) with 
severe mitral valve insufficiency (Table 7) and (Figure 10). 
     Table 6: Down syndrome patients characteristics (D) 
 Number (%) 
Rastelli type A 62 83.8 
Rastelli type B 8 10.8 
Rastelli type C 4 5.4 
Pulmonary hypertension 56 75.7 
Tetralogy of Fallot 5 6.8 
Severe MI 1 1.4 
  
     Table 7: Non- Down syndrome patients characteristics (ND) 
 Number (%) 
Rastelli type A 31 86.1 
Rastelli type B 3 8.3 
Rastelli type C 2 5.6 
Pulmonary hypertension 13 36.1 
Tetralogy of Fallot 1 2.8 
Severe MI 5 13.9 
 
The incidence of severe mitral insufficiency was significantly lower among patients in 
group D compared with group ND, while the incidence of pulmonary hypertension, 
respiratory infection and associated tetralogy of Fallot was higher among patients in group 
D compared with group ND. 
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Figure 9: Preoperative presenting symptoms in Down and non- Down syndrome 
patients. 
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Figure 10: Rastelli types in Down syndrome and non- Down syndrome patients. 
 
      Other coexisting extracardiac congenital anomalies were observed in 11 patients (10%) all     
      of them except one had Down syndrome, these anomalies including congenital cataract,  
      Hirschsprung`s disease, congenital tracheal stenosis, anal atresia, und umbilical hernia. 
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4.1.2. Diagnosis      
By all patients the diagnosis was made or confirmed by echocardiography and all patients 
were in sinus rhythm. In the preoperative echocardiography were 6 patients with mitral 
insufficiency grade III (5.5%), while 104 patients (94.5%) had no or mild mitral 
insufficiency. Cardiac catheterization was done for 79/110 (71.8%), only 2/79 (2.5%) had 
complications, 1 patient suffered of leg ischemia, the second had an arterio- venous fistula 
(femoral). Both were successfully treated without residual complications. In 74/110 
patients (67.3%), AVSD was associated with Down syndrome, and the other most common 
coexisting cardiac anomalies were: patent ductus arteriosus 35/110 (31.8%), persistent left 
superior vena cava 7/110 (6.4%), RVOTO (Fallot tetralogy) 6/110 (5.5%), aortic 
coarctation 5/110 (4.6%), coronary origin anomalies 2/110 (1.8%), aberrant right 
subclavian artery 1/110 (0.91%). None of the patients presented with LVOTO (0%). In 
25/110 patients (22.7%) the ventricles were unbalanced, out of these only 2/110 (1.82%) 
were with border line hypoplastic left ventricle, 24 patients with right ventricle dominance 
and 1 patient with left ventricle dominance (Table 8). Seventeen patients (22.9%) in group 
D and 8 patients (22.2%) in group ND were found to have unbalanced ventricles. 
 
     Table 8 : Coexisting cardiac anomalies and congenital anomalies 
 Number   (%)  
Down syndrome   74 67.3   
Non- Down patients (ND) 36 32.7 
Patent ductus arteriosus 35 31.8 
Persistent left superior vena cava  7 6.4 
RVOTO (Fallot tetralogy) 6 5.5 
Aortic coarctation 5 4.6 
Coronary artery anomalies 2 1.8 
Aberrant right subclavian artery 1 0.9 
Unbalanced ventricles 25 22.7 
Hypolastic left ventricle (border line) 2 1.8 
Mitral regurgitation grade III 6 5.5 
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4.1.3. Preoperative anticongestive therapy 
The patients with AV septal defects, who required preoperatively medical therapy, were 70 
(63.6%). This was consisting mainly of anticongestive drugs, the mainstays were lasix for 
diuresis, digoxin as a mild inotrope, and B- blockers plus ACE inhibitors for afterload 
reduction. In addition to that symptomatic treatment for example, thyroxine for 
hypothyrosis, and antibiotics for respiratory infection were administerd. 
 
4.1.4. Preoperative palliative procedures 
The choice to proceed to primary repair or to palliative procedure was based on the pre- 
operative clinical condition, echocardiography assessement and on the direct inspection of 
the heart at the time of operation. In 10/110 patients (9.1%) palliative procedures were 
done, including aorto- pulmonary shunts in 2/110 patients (1.8%), and pulmonary artery 
banding and rebanding in 8/110 (7.3%) (Table 9). In addition to that 3 patients underwent 
aortic coarctation  repair (at the same time with banding). One of the aortic coarctation was 
left without correction because of its low grade and in the other patient, the correction was 
done at the same time with AV septal repair.  All patients who underwent pulmonary artery 
banding procedures had pulmonary hypertension secondary to pulmonary overflow, 3 
patients had right ventricle dominance, 4 patients had balanced ventricles, and 1 patient had 
left ventricle dominance. Those who underwent aorto- pulmonary shunt procedures (n = 2) 
had RVOTO, both of them had balanced ventricles. The palliative procedures were 
necessary in 9 patients (12.2%) in group D, and in 1 patient (2.8%) in group ND. This 
patient in the ND group underwent pulmonary artery banding. 
     Table 9: Palliative procedures 
 Number (%) 
Aorto- pulmonary shunt 2 1.82 
Pulmonary artery banding and coarctation repairs 8 7.27 
Total 10 9.09 
 
 
4.2. Intraoperative data 
4.2.1. Operative techniques 
After the routine aorto- bicaval cannulation, CPB with mild hypothermia had been 
established, antegrade cold Bretschneider cardioplegia was infused. Two- patch or single- 
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patch technique was done depending on the anatomical finding. Sixty- five patients 
(87.8%) in group D and 35 patients (97.2%) in group ND underwent primary AVSD repair. 
From those patients with Down syndrome 63/74 patients (85.1%) underwent two- patch 
technique repair and 11/74 patients (14.9%) underwent single- patch technique, while in 
group ND 18 patients (50%) underwent two- patch technique and 18 patients (50%) 
underwent single- patch technique. This revealed that more patients in group D underwent 
two- patch techniques compared with patients in group ND (Figure 11). The details of the 
operation of all patients were: one patient underwent a single-patch technique plus left side 
and right side AV valve repair and aorta coarctation repair (0.91%); 14 patients underwent 
a single- patch technique plus mitral valve repair (12.7%), 2 combined with PDA ligations; 
14 patients underwent a single- patch technique plus left and right side AV valve repair 
(12.7%), 4 combined with PDA ligations; 3 patients underwent two- patch technique plus 
left and right side AV valve repair and pulmonary artery patch enlargement at the previous 
banding site (2.7%); 6 patients underwent 2- patch technique plus left and right side AV 
valve repair (1 patient had MV- replacement) and Fallot tatralogy correction (5.5%). From 
these, 1 patient received a Contegra graft, while the others had infundibular muscular 
resection and transannular patch enlargement or pulmonary valve commissurotomy; 19 
patients underwent two- patch repair plus both AV valves repair and PDA ligation and 
resection (17.3%), 53 patients underwent two- patch technique plus left and right side AV 
valve repair (48.2%). In addition to AVSD repair there were 3 persistent left superior vena 
cava re-routing to the right. In total 29 patients (26.4%) underwent single- patch technique, 
including the patients with partial AVSD (n = 4). Eighty- one patients (73.6%) underwent 
two- patch technique (Table 10). In 99/110 patients (90%) the pericardial patch which used 
to close the ASD, was sutured so that the coronary sinus drained into the left atrium. By all 
patients the assessment of the morphologic and functional result was done by 
transesophageal two- dimentional color flow Doppler echocardiography. Seven patients 
required operative revision, from those, 5 patients with reinstitution of cardiopulmonary 
bypass; 4 patients showed severe residual mitral regurgitation, with 2 patients of them 
underwent MV repairs. The third patient was revised for residual mitral regurgitation and 
RVOTO. This patient underwent MV repair and pulmonary artery patch enlargement at the 
previous banding site. This patient later on underwent heart transplantation because of 
chronic heart failure. The fourth patient with residual mitral valve regurgitation underwent 
mitral valve replacement (mechanical, carbomedics- 16 mm). The fifth patient showed 
LVOTO. The reason of the obstruction was based on the VSD patch. This patient was 
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revised with the use of a new patch. Two patients suffering of cardiac tamponade 
underwent re-thoracotomy. In one of them an artificial 4 mm ASD was performed in the 
catheter lab because of high pulmonary pressure. We noticed, that only 1 patient (1.4%) in 
D group underwent revision with reinstitution of HLM, while 4 patients (11.4%) in group 
ND underwent revisions, which is quite significant. 
 
Single/ Two- patch technique
50 50
26.4
14.9
73.6
85.1
0
10
20
30
40
50
60
70
80
90
All patients D patients ND patients
( %
 ) Single- patch
Two- patch
 
Figure 11: Single- patch and two- patch technique in all patients, Down syndrome 
patients and non- Down syndrome patients. 
 
     Table  10:  Operative techniques 
 Number (%) 
Single- patch +  MV repair + TV repair +  Coarctation repair 1 0.91 
Single- patch + MV repair (2-PDA) 14 12.7 
Single- patch +  MV repair + TV repair (4-PDA) 14 12.7 
Two- patch + MV repair + TV  repair + PA-patching. 3 2.7 
Two-patch + MV repair + TV repair + Fallot repair 6 5.5 
Two-patch + MV repair + TV repair +  PDA 19 17.3 
Two-patch + MV repair + TV repair 53 48.2 
Total single- patch technique 29 26.4 
Total two- patch technique 81 73.6 
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Following surgery, the chest left open in 5 patients (closed only by pericardial membrane), 
in addition to that the chest was reopened in 1 patient because of hemodynamic instability. 
In all those patients, the chest was closed later on secondarly. In 4 patients the chest was 
closed directly after revision operations.  
  
4.2.2. CPB duration and aortic- cross clamping 
For all patients, the mean CPB time was 151 ± 60.5 min., while the median was 143 min.   
(range, 66- 326 min.), and the mean aortic cross clamping time was 88 ± 35 min., the 
median was 83.5 min. (range, 32- 207 min.) (Table 11). The mean CPB time in group D 
was 159.3 ± 56 min., and the mean CPB time in group ND was 133.9 ± 66.5 min.. The 
two- tailed p- value was considered significant (p = 0.0382) (Figure 12). The mean aortic 
cross clamping in group D was 95.3 ± 34.5 min., and in group ND was 73.1 ± 32.9 min.. 
The p- value was also considered significant (p = 0.0017). In 106/110 patients (96.4%), 
erythrocytes concentrates were used as a priming for ECC. The difference in CPB and 
aortic cross clamping times between the 2 groups may be attributed to the higher rate of 
using two- patch techniques in group D. 
In the patient with the longest Bypass time (326 min.) the operative course was very 
complicated, because of the difficulty to repair the left sided AV valve, in the border line 
hypoplastic LV and difficulty to wean from HLM. This patient later on underwent 
successful heart transplantation. 
 
     Table  11 : Bypass time and aortic cross clamping 
 Mean SD Median Range 
Bypass time (min.) 151 60.5 143 66- 326 
Aortic cross clamping (min.) 88 35 83.5 32- 207 
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Figure 12: CPB and aortic cross clamping times. 
 
4.2.3. Intraoperative  complications 
Pulmonary hypertensive crisis occurred in 13/110 of patients (11.8%), complete AV block 
occurred in 10 patients (9.1%), which necessitated external pacing (some of them were 
temporary). Weaning difficulty from HLM of different causes occurred in 6 patients 
(5.5%). Difficulty to repair mitral valve because of dysplastic AV valve and persistent 
mitral regurgitation grade III-IV, occurred in 4 patients (3.6%). Electrocardiography 
changes due to air embolism occured in 2/110 (1.8 %). Junctional ectopic rhythm occurred 
in 2 patients (1.8%), other rhythm disturbances (Sinus tachycardia, supraventricular 
extrasystole, sick sinus syndrome ) occurred in 4 patients (3.6%). Right side AV valve 
regurgitation III-IV occurred in1 patient (0.9%). Intraoperative bleeding due to long CPB 
time occurred in 1 patient (0.9%). Protamine allergy occurred in 1 patient (0.9%). 
Operative mortality which is defined as death within the operative and postoperative 
hospitalization or within 30 days from surgery was 1 patient (0.91%) due to severe mitral 
regurgitation grade IV and pulmonary hypertensive crisis which lead to right ventricular 
failure (Table 12). In the group D, 10 patients (13.5%) had introperative pulmonary 
hypertensive crisis, 7 patients (9.5%) had complete AV block, and 1 patient (1.4%) had 
severe MI. In group ND, 3 patients (8.3%) had pulmonary hypertensive crisis, 3 patients 
(8.3%) had complete AV block, 3 patients (8.3%) had severe MI, and 1 patient died (2.8%). 
The weaning difficulty from HLM was the same in both groups, with 3 patients for each 
group.  
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      Table  12: Intraoperative complications and rhythm disturbances 
  No. (%) 
1. Pulmonary hypertensive crisis 13 11.8 
2. Complete AV block (some of them were temporary) 10 9.1 
3. Weanig difficulty from HLM 6 5.5 
4. Mitral valve insufficiency (III-IV) and difficult repair 4 3.6 
5. Electrocardigraphy changes 2 1.8 
6 Junctional ectopic rhythm 2 1.8 
7. Other rhythm disturbance (SVES, Sinus tachycardia,  SSS) 4 3.6 
8. Right side AV valve regurgitation (III-IV) 1 0.9 
9. Intraoperative bleeding 1 0.9 
10. Protamine allergy 1 0.9 
11. Operative death 1 0.9 
 
 
4.2.4. Thorax closure 
Primary thorax closure was possible in 105/110 of patients (95.5%), but later on in 1 
patient from those who underwent primary closure, the chest was re-opened and closed 
only by pericardial membrane because of hemodynamic instability. In 6 patients (5.5%) 
thorax was left opened and closed only with a pericardial membrane, because of heart 
edema, hemodynamic instability and hemostasis problems (bleeding) (Table 13).  
The primary thorax closure was done in 72 patients (97.3%) in group D and in 32 patients 
(88.9%) in group ND. 
 
     Table 13 : Thorax closure in all patients 
 Number (%) 
Primary closure 105/110 95.5  
Secondary closure 6/110 5.5 
Operative revisions 7/110 6.4 
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4.3. Postoperative data 
4.3.1. Catecholamine therapy 
Inotropic agents like, epinephrine, norepinephrine, dobutamine,dopamine and milrinone® 
were used to support the circulation in the postoperative period in 82 patients (75.2 %). 
The mean duration of catecholamines support was 3.3 ± 4.5 days, the median was 2 days            
(range, 0- 34 days). The mean duration of inotropic therapy in group D (n = 58) was 2.8 ± 
2.2 days, and in group ND (n = 24) was 4.7 ± 7.5 days. The two- tailed p- value was 0.0467 
which is considered significant. The patients in group ND showed a significantly longer 
period need for inotropic support compared to group D patients.     
 
4.3.2. Additional therapy 
For preload reduction nitroglycerine as a continuous infusion was used and for diuresis, 
lasix® was used as a single dose or continuous infusion. In addition to that 66/109 of 
patients (61%) discharged with aldactone, lasix , B- blockers and captopril therapy, which 
stopped during the follow- up period. 
 
4.3.3. Mechanical ventilation 
All patients were transferred from operating room to intensive care unit intubated and 
controlled ventilated. In the intensive care unit the patients were under pressure controlled 
mechanical ventilation, which was adjusted to optimize preload and decrease afterload. At 
first the oxygen concentration was 100%, which was later on in case of good oxygen 
saturation reduced gradually. The mean intubation time for all patients was 3.5 ± 4.8 SD 
days, the median was 2.5 days (range, 0- 39 days). The mean duration of mechanical 
ventilation in group D patients was 3.5 ± 3.2 days and in group ND patients was 3.6 ± 7.1 
days, the p- value was 0.9189 which is considered not significant. The longest intubation 
time was in 1 patient (39 days) who had severe mitral regurgitation after AVSD repair. 
Then he underwent mitral valve repair which was failed, then he suffered chronic heart 
failure and lastly underwent heart transplantation. The mean intensive care unit stay was 
6.5  ± 7.3 SD days, the median was 6 days (range, 0- 71 days) (Table 14). 
The mean duration of intensive care unit stay, was in group D patients 6.5 ± 3.8 days, and 
in group ND patients was 6.4 ± 11.7 days, the p- value was 0.9469 which is considered not 
significant.  
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     Table 14: Mechanical ventilation and ICU stay in days for all patients 
 Mean SD Median Range 
Mechanical ventilation (d) 3.5 4.8 2.5 0- 39 
ICU stay (d) 6.5 7.3 6 0-71 
 
 
4.3.4. Secondary thorax closure 
The secondary chest closure was done in 6 patients. Five patients already came from the 
operation room with open thorax. One patient was reopened after primary chest closure 
because of hemodynamic instability (pericard tamponade). Four of those patients who had 
opened thorax, had also postoperative revision, to be closed directly after the revision 
operation. The mean period for secondary chest closure was 3.8 days ± 1.8 SD and the 
median was 3 days (range, 2- 7 days) after surgical repair. Two patients (2.7%) from  group 
D underwent secondary closure and 4 patients (11.4%) from group ND had secondary 
closure. None died from the patients who underwent secondary closure. 
 
4.3.5. Postoperative rhythm disturbances 
 In the postoperative period, in 67 patients (61.5%) rhythm disturbances in the form of 
junctional ectopic tachycardia, supraventricular tachycardia, supraventricular extrasystole, 
ventricular extrasystole, ventricular tachycardia, sinus tachycardia, bradycardia (including 
temporary and permanent AV block from I-III grade), atrial fibrillation and flutter was 
found in electrocardiography. Almost in the majority they were temporary. Incomplete 
right bundle branch block was found in ECG of 35 patients (32.1%) and complete right 
bundle branch block was found in ECG of others 35 patients (32.1%) (Table 15). At 
discharge 100 patients had sinus rhythm (91.7%), 3 patients had AV junctional ectopic 
rhythm (2.8%), and 6 patients had permanent pacemaker because of complete AV block. In 
the patients in group D there were 71 patients (95.9%) with sinus rhythm, 2 patients (2.7%) 
with junctional ectopic rhythm and 1 patient (1.4%) required pacemaker implantation due 
to complete AV block. In group ND there were 29 patients (82.9%) with sinus rhythm, 1 
patient (2.9%) with junctional ectopic rhythm and 5 patients (14.2%) required pacemaker 
implantation due to complete AV block. The patients in group ND had a significant higher 
rate of complete AV block compared with those in group D postoperatively. 
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      Table 15: Postoperative ECG rhythm disturbance findings 
 Number (%) 
Junctional ectopic tachycardia. 20/109 18.4 
Supraventricular tachycardia and or suprventricular extrasystole. 11 10 
Ventricular tachycardia and or ventricular extrasystole. 4 3.7 
Sinus bradycardia 25 22.9 
Atrial fibrillation and or flutter 1 0.9 
Sinus tachycardia 6 5.5 
Temporary AV block 14 12.8 
Permanent AV block 6 5.5 
Incomplete right bundle branch block 35 32.1 
Complete right bundle branch block 35 32.1 
 
 
4.3.6. Postoperative complications 
In the operative and postoperative period 48 patients (44%) suffered from pulmonary 
hypertensive crisis, characterized by rapid rise in pulmonary pressure, accompanied by 
bronchospasm and reduced blood pressure and oxygen saturation. All of them had 
remission under deep sedation, muscle relaxation, increased FiO2, hyperventilation, nitric 
oxide inhalation, illomedin and flolan therapy. The mean duration of therapy for all patients 
was 5.6 days ± 3.5, the median was 5 days (range, 1- 14 days). The mean duration of 
therapy in D group patients (n = 35) was 5.2 ± 2.9 days, and in ND group patients (n = 9) 
was 7.1 ± 5.3 days. The p- value was 0.0173 which is significant. At discharge there were 
only 10 patients with persistent pulmonary hypertension (14.5%) from the patients who 
have preoperatively pulmonary hypertension, which represents 9.2% from all patients 
(10/109). Seven patients of them were in group D (9.5%) and 3 in group ND (8.6%). All of 
them were discharged on sildenafil, illomedin and anticongestive therapy to be followed- 
up, one patient of them had normal pulmonary pressure after mitral valve replacement 2 
months later. The other postoperative complications included: Thirty- two patients with 
respiratory infection, 28 patients with pleural effusion (only 3 patients required draining, 
while the others treated medically), 26 patients with atelectasis, 25 patients with respiratory 
obstruction and or stridor, 15 patients with pericardial effusion (only 2 required re-
thoracotomy), 5 patients with lung edema, 4 patients with ascitis (all drained), 3 patients 
had chylothorax (treated medically), 3 patients suffered from a cardiogenic shock, 2 
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patients had severe bleeding (which was compensated after transfusion of fresh frozen 
plasma, platelets and erythrocytes concentrations), 2 patients had sepsis, 1 patient had 
postcardiotomy syndrome, 1 patient had renal dysfunction, and 1 patient had temporary 
neurological deficits (Table 16).  
In group D patients, 24 patients (32.4%) had respiratory infection, 22 patients (29.7%) had 
pulmonary atelectasis, 21 patients (28.4%) had stridor, and 3 patients (4.1%) had 
pulmonary edema, while in group ND, 8 patients (22.9%) had respiratory infection, 4 
patients (11.4%) had atelectasis, 4 patients (11.4%) had stridor and 2 patients (5.7%) had 
pulmonary edema (Figure 13). The patients with Down syndrome had a higher rate of 
respiratory infection, more tendency to develop stridor and atelectasis compared to group 
ND but this was not associated with long mechanical ventilation or ICU stay in  group D. 
 
     Table 16:  Postoperative complications 
 Number (%) 
Pulmonary hypertensive crisis 48 44.04 
Respiratory infection 32 29.4 
Pleural effusion 28 25.7 
Atelectasis  26 23.9 
Respiratory obstruction and or stridor 25 22.9 
Pericardial effusion 15 13.8 
Lung edema 5 4.6 
Ascitis 4 3.7 
Chylothorax 3 2.8 
Cardiogenic shock 3 2.8 
Bleeding 2 1.8 
Sepsis 2 1.8 
Postcardiotomy syndrome 1 0.9 
Renal dysfunction 1 0.9 
Temporary neurological deficits 1 0.9 
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Figure 13: Main postoperative complications. 
 
4.3.7. Postoperative residual findings- echocardiography findings 
In all living patients (109) postoperative control echocardiography was done which was 
used not only to judge the hemodynamic situation but also in the decision making for 
revisions in 7 patients in the postoperative period. Four patients of them had already open 
chest in the postoperative period, due to hemodynamic instability. The echocardiography 
findings by discharge in all patients (109): mitral valve regurgitation was grade (0-I ) in 75 
patients, MI grade (II) in 27 patients, MI grade (III) in 7 patients, and MI grade (IV) no 
patient. From those patients who had preoperative MI grade III (n = 6), 2 patients 
postoperatively still had MI grade (III), 3 patients had MI grade (II), and 1 patient had MI 
grade (I). Mild grade mitral stenosis was seen in 2 patients which was hemodynamically 
not significant. Tricuspid valve regurgitation was grade (0-I) in 101 patients, TI grade (II) 
in 7 patients, and TI grade (III) in 1 patient. Aortic valve regurgitation was grade (I–II) in 2 
patients, and pulmonary valve regurgitation was grade (I –II ) in 2 patients. Residual small 
VSD without gradient was seen in 31 patients (Table 17). 
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     Table 17: Echocardiographic residual findings at discharge 
 Number (%) 
Mitral regurgitation grade (0–I) 75 68.8 
Mitral regurgitation grade (II) 27 24.8 
Mitral regurgitation grade (III) 7 6.4 
Mitral regurgitation grade(IV) 0 0 
Mitral stenosis (mild) 2 1.8 
Tricuspid regurgitation grade (0-I) 101 92.7 
Tricuspid regurgitation grade (II) 7 6.4 
Tricuspid regurgitation grade (III) 1 0.9 
Aortic regurgitation grade (I-II) 2 1.8 
Pulmonary regurgitation grade (I-II) 2 1.8 
Small residual VSD without shunt 31 28.4 
 
From those patients who underwent two- patch technique (81 patients), 1 patient died, 
43/80 patients had mitral valve regurgitation (I), 21 patients had mitral valve regurgitation 
(II), 7 patients had mitral valve regurgitation (III), and 9 patients had no mitral valve   
regurgitation. In 29 patients with single- patch technique, 22 patients had mitral valve 
regurgitation (I), 6 patients had mitral valve regurgitation (II), and 1 patient had no mitral 
valve regurgitation. In the group of Down syndrome patients, 70 patients (94.6%) had no or 
mild mitral valve regurgitation, and 4 patients (5.4%) had moderate to severe mitral 
regurgitation. In the ND group, 32 patients (91.4%) had no or mild mitral valve 
regurgitation and 3 patients (8.6%) had moderate to severe mitral valve regurgitation 
(Table 18 and 19) (Figure 14). 
     Table 18: Two/ Single- patch technique and MV regurgitation postoperatively 
 MI (I) MI (II) MI (III) MI (IV) 
Two- patch technique (80/81) 43  21 7 0 
Single- patch technique (29) 22 6 0 0 
 
     Table 19: Down /non- Down patients and MV  regurgitation postoperatively 
 D group (%) ND group (%) 
No or mild MI 70 94.6 32 91.4 
Moderate to severe MI 4 5.4 3 8.6 
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Figure 14: Residual MI postoperatively. 
 
4.3.8. Early mortality 
The early mortality after atrioventricular septal defect repair was 1/110 patient (0.91%). 
This occurred in the operation room, due to severe mitral valve regurgitation, which was 
difficult to repair. Pulmonary hypertensive crisis developed which lead to right ventricular 
dilatation and right ventricular failure. This patient belonged to group ND (2.8%) and had 
right ventricular dominance. Several variables were analyzed to assess if they were risk 
factors for operative mortality. These variables included age, sex, body weight of patients, 
preoperative palliative procedures and respiratory compromise requiring ventilation. Only 
age (< 4 months), body weight (< 4 kg), and in addition to that, non- Down patients were  
identified as an independent risk factor for early mortality.  
The life expectancy for all patients expected to be a straight line (99.1%), because only one 
patient (0.91%) died intraoperatively and that is the reason not to use Kaplan- Meier 
method for estimating survival. 
 
4.3.9. Discharge 
The mean hospital stay was 16.7 ± 12.4 days, the median was 13 days (range, 3- 80 days). 
The mean hospital stay for group D patients was 16.7 ± 10.5 days (median = 14.5 days), 
while for group ND patients was 16.8 ± 15.8 days (median = 14.5 days). The p- value was 
0.9688 and is considered not significant. The longest stay was in a patient with complicated 
postoperative course with severe dysplastic mitral valve, long CPB and aortic cross clamp 
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durations 323/205 min., respectively. At discharge only 10 patients still had pulmonary 
hypertension with good response to therapy (9.2%), 100 patients had sinus rhythm (91.7%), 
6 patients needed a permanent pacemaker (5.5%) and 3 patients were with atrioventricular 
junctional rhythm (2.8%). Also at discharge only 66 patients were on temporary 
anticongestive therapy including, Diuretics, ACE inhibitors and B- blocker (61%). The 
mean oxygen saturation at discharge was 98 % ± 1.6, the median was 99 % (with range, 
94- 100 %). The mean pulmonary artery pressure was 21.8 mmHg ± 6.6, the median was 
21 mmHg (range,10- 55 mmHg). From 109 living patients were 94 patients (86.2%) 
discharged to home and 15 patients (13.8%) to the referring  hospital (Table 20 and Table 
21).  
 
     Table 20: Clinical profile at discharge 
 Mean SD Median Range 
Hospital stay (d) 16.7 12.4 13 3- 80 
Oxygen saturation (%) 98 1.6 99 94- 100 
Mean pulmonary pressure (mmHg) 22.1 7.4 21 10- 56 
Discharge weight (kg) 9.2 10.4 5.96 3.39-64.7 
 
 
      Table 21: Clinical findings at discharge 
 Number  (%) 
Persistent pulmonary hypertension 10 9.2 
Sinus rhythm 100 91.7 
Permanent pacemaker 6 5.5 
Junctional ectopic rhythm 3 2.8 
Anticongestive therapy (temporary) 66 61 
Discharge to home 94 86.2 
Discharge to referring hospital 15 13.8 
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5. Late results and follow- up 
5.1. Re- admissions 
During the follow- up period 32 patients were readmitted (30.5%) to the different 
departments, with a total number of admissions equal to 75 times. The readmissions for 
surgical purposes were in different surgical departments and also for interventional cardiac 
catheterization. The readmissions for medical treatment were also in different departments, 
including paediatric cardiology and paediatric neurology. Cardiac catheterization was done 
in 16 patients, including 14 times for diagnostic purposes and 2 times for therapeutic 
purposes. For therapeutic purposes, 1 case was for implantation of VSD occluder system, 
which was complicated with injury to one of the aortic valve cusps, repaired surgically in 
the same day with the use of cardiopulmonary bypass. In the second case the patient 
underwent implantation of coils in patent ductus arteriosus (PDA). The other operative 
causes of readmission, included adenoidectomy, tonsillectomy, congenital cataract 
operation and teeth extraction. For therapy adjustment, it was 1 time for immunosuppresive 
therapy and 2 times for marcumar adjustment. The readmissions included also 5 times 
pacemaker implantation and or change and 2 times pacemaker explantations (Table 22). 
     Table 22: The causes of readmission 
 Number of patients (%) 
Redo and or transplantation 21 20 
Cardiac catheterization (diagnostic and therapeutic) 16 15.2 
Other operative causes (non- cardiac) 8 7.6 
Respiratory infection 6 5.7 
LVOTO / Subaortic stenosis 6 5.7 
Cardiac failure 5 4.8 
Pacemaker implantation or change 5 4.8 
Fever 4 3.8 
Marcumar or Immunosuppresive adjustment 3 2.9 
Pacemaker explantation 2 2.9 
Bronchoscopy 2 2.9 
Endocarditis 1 0.95 
Pericardial effusion 1 0.95 
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     5.2. Late operative interventions (Redo) 
Twenty- one patients (21/105 = 20%) underwent 24 reoperations during the follow- up 
period plus 2 patients in the direct postoperative period who did not need further 
interventions during follow- up, one of them had MV repair and the other one had 
permanent pacemaker implantation, so that the total patients who needed reoperations were 
23 patients (21.9%). Those included subaortic fibromuscular ridge resections (n = 5), left 
ventricular outflow tract obstruction due to VSD Dacron patch (n = 1), Mitral valve repair 
(n = 9), mitral valve replacements (n = 5), VSD occluder implantation in the catheter lab (n 
= 1), and PDA coil closure (n = 1). These 24 reoperations, included 2 heart transplantations 
after atrioventricular septal defects repair. The cause of transplantation in the first case was 
severe residual mitral regurgitation and chronic cardiac failure 20 months after the first 
operation. In the second case, the cause was severe residual mitral valve regurgitation after 
revision and end stage cardiac failure. This patient had a hypoplastic left ventricle and 
preoperative pulmonary artery banding, and received heart transplantation 34 days after 
AVSD repair. In addition to that; 5 patients underwent revisions in the direct postoperative 
period, 4 of them came later on for mitral valve replacement or repair or sub-aortic 
obstruction revision and for transplantation, and the fifth patient had no further 
intervention. Three of the patients (3/6) who had preoperatively severe left side AV valve 
insufficiency, underwent mitral valve repair or replacement in the follow- up period. This 
shows a higher rate of MV reoperations in patients who had preoperatively severe MI 
(Table 23).  The mean time from the AVSD repair to the first reoperation or transplantation 
for all patients was 22.3 months ± 22.6, the median was 16 months (range, 34 days- 7.6 
years). The mean time from the AVSD repair to the second reoperation or transplantation 
was 5.6 years ± 4.3, the median was 5 years (range, 1.7- 10.2 years) (Table 24).  
Within the follow- up period 9/71 patients (12.7%) in group D and 14/34 patients (41.2%) 
in group ND required reoperation after AVSD primary repair. In total there were 9 
reoperations in group D plus 2 catheter interventions and 3 pacemaker implantations. The 
reoperations included; 5 MV reoperations (MV repair,n = 3 and MV replacement,n = 2), 4 
LVOTO repairs. In group ND there were 16 reoperations, plus 2 heart transplantations and 
6 pacemaker implantations. The reoperations included; 13 MV reoperations (9 MV repair 
and 4 MV replacement), 3 LVOTO repairs and 2 heart transplantations. This shows that the 
main indication for reoperation in both groups was severe mitral valve insufficiency, 
followed by pacemaker implantations, and LVOTO repairs, with higher rate of reoperations 
in group ND compared to group D. The freedom from any type of reoperations at 10 years 
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for all patients was 80% (Figure 15). The freedom from MV repair reoperation at 10 years 
was 87% (Figure 16), the freedom from MV replacement reoperation at 10 years was 95% 
(Figure 17), the freedom from LVOTO repair reoperation at 10 years was 88% (Figure 18), 
and the freedom from pacemaker implantation at 10 years was 92% (Figure 19). In Down 
syndrome patients the freedom from any redo at 10 years was 90% (Figure 20) and in ND 
patients group the freedom from any redo at 10 years was 50% (Figure 21). 
 
      Table 23: Type of reoperations 
 Number (%) 
Mitral valve replacement (mechanical valves) 5 4.8 
Mitral valve repair 9 8.6 
Subaortic fibromuscular resection 5 4.8 
LVOTO patch reconstruction or reposition 1 0.95 
Heart transplantation 2 1.9 
VSD occluder implantation 1 0.95 
PDA coil closure 1 0.95 
Total number of reoperations 24 22.9 
 
       
     Table 24: The duration to first & second redo after AVSD repair    
 Mean SD Median Range 
First reoperation 22.3 (m) 22.6 (m) 16 (m) 34 (d)- 7.6 (y) 
Second reoperation 5.6 (y) 4.3 (y) 5 (y) 1.7 (y)- 10.2 (y) 
       
 
      It should be noted that 22 patients underwent revisions or reoperations with a total of 29 
reoperations or interventions, with 7 patients underwent re-re-operations, all of them except 
one underwent two-patch technique. Sixteen patients underwent two- patch technique 
(19.8%) with 22 reoperations (75.9%), and 6 patients underwent single- patch technique 
(20.7%) with 7 reoperations (24.1%) (Table 25 and 26). 
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      Table 25: Two- patch technique and reoperations 
 Patients (%) Reoperations (%) 
Two- patch technique (Total) 16/81 19.8 22/29 75.9 
Mitral valve repair and or replacement 11/81 13.6 12/29 41.4 
Subaortic obstruction repair 4/81 4.9 6/29 20.7 
Transplantation 2/81 2.5 2/29 6.9 
VSD occluder implantation 1/81 1.2 1/29 3.4 
PDA coil closure 1/81 1.2 1/29 3.4 
 
      Table 26: Single- patch technique and reoperations 
 Patients (%) Reoperations (%) 
Single- patch technique (Total) 6/29 20.7 7/29 24.1 
Mitral valve repair and or replacement 6/29 20.7 6 20.7 
Sub-aortic obstruction repair 1/29 3.4 1 3.4 
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Figure 15: Kaplan-Meier estimate of freedom from any reoperation for all     
patients. 
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    Figure 16: Kaplan-Meier estimate of freedom from MV repairs reoperation. 
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Figure 17: Kaplan-Meier estimate of freedom from MV replacements   
reoperation. 
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Figure 18: Kaplan-Meier estimate of freedom from LVOTO repairs reoperation. 
 
 
 
    Figure 19: Kaplan-Meier estimate of freedom from pacemaker implantations. 
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 Figure 20: Kaplan-Meier estimate of freedom from any reoperation by Down´s  
patients. 
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Figure 21: Kaplan-Meier estimate of freedom from any redo by non- Down´s 
patients. 
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5.3. Follow- up 
5.3.1. General findings 
After discharge from hospital, the follow- up was conducted in the polyclinic of the 
department of pediatric cardiology, in the Pediatric Heart Center, Giessen as well as by 
pediatric cardiologists of the regional hospitals. The follow- up was possible for 105 
patients from 109 patients who were discharged living from the hospital (96.3%). The other 
4 patients were lost. During follow- up visit, the general condition of the patients was 
assessed, in addition to that the patient´s body weight, height, blood pressure were 
measured. The patient´s present complaints as well as medication was inquired. Then 
general physical  and cardiopulmonary examinations were performed, additionally to that 
also electrocardiography and echocardiography. Only 16 patients needed cardiac 
catheterization (including, 2 times therapeutic interventional and 14 times diagnostic for 
those patients who were dischraged with signs of pulmonary hypertension and also before 
reoperation to assess the pulmonary vascular resistance). The mean follow- up period was 
3.5 ± 3.2 years, the median period was 2.5 years (range, 13 days- 10.9 years). No deaths 
were recorded, 97 patients were found with functional status NYHA I (92.4%), 7 patients 
with NYHA II (6.7%), and 1 patient with NYHA IV (0.95%). The mean follow- up for D 
group 71/74 patients was 3.5 ± 3.2 years, and for ND group 34/35 patients was 3.4 ± 3.3 
years. The functional status, electrocardiographic, and echocardiographic findings in Down 
and non- Down patients are summarised in Table 27. 
 
     Table 27: Follow- up findings in D and ND patients 
 D (%) ND (%) 
Good biventricular function 70/71 98.6 34/34 100 
NYHA I-II 70 98.6 34 100 
NYHA IV 1 1.4 0 0 
Severe mitral valve regurgitation 2 2.8 2 5.9 
Sinus rhythm 67 94.4 31 91.2 
Permanent pacemaker due to complete AV block 3 4.2 3 8.8 
  
From the table we can see that the group ND patients are more prone to severe mitral 
insufficiency and complete AV block compared to group D patients. 
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5.3.2. Electrocardigraphy findings 
Ninety- eight patients were found to have sinus rhythm (93.3%), 6 patients having 
permanent pacemaker because of complete AV block (5.7%), including 3 patients who 
already were discharged with permanent pacemaker after the primary repair of AVSD and 
3 other patients who got complete AV block during the follow- up period and consequently 
underwent permanent pacemaker implantation, and 1 patient with atrioventricular ectopic 
rhythm (0.95%). Forty- four patients were found with complete right bundle branch block 
(41.9%), 34 patients were found with incomplete right bundle branch block (32.4%). 
 
5.3.3. Echocardiography findings 
The echocardiography findings for 105 patients during follow- up can be summarized as 
104 patients (99.1%) had good biventricular function and 1 patient (0.95%) had reduced 
ventricular function. Eight patients (7.6%) had no mitral regurgitation, mitral valve 
regurgitation grade I was found in 68 patients (64.8%), mitral regurgitation grade II in 25 
patients (23.8%), mitral regurgitation grade III in 3 patients (2.9%), and mitral 
regurgitation grade IV in 1 patient (0.95%). Tricuspid regurgitation grade I was found in 63 
patients (60%), tricuspid regurgitation grade II in 7 patients (6.7%) and tricuspid 
regurgitation grade IV in 1 patient (0.95%). At the same time pulmonary valve 
regurgitation grade I was found in 10 patients (9.5%), and aortic valve regurgitation grade 
I-II in 9 patients (8.6%). In none of the patients any signs of mitral stenosis or tricuspid 
stenosis were diagnosed. Residual small VSD without shunt was found in 16 patients 
(15.2%), signs of pulmonary hypertension were found in 2 patients (1.9%), and LVOTO 
was found in 2 patients (1.9%), one of those patients with a LVOTO had a gradient equal to 
22 mmHg, the other had a gradient equal to 25 mmHg (Table 28). 
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     Table 28: Follow- up findings in all patients 
 Number  (%) 
Total follow- up 105 96.3 
Sinus rhythm 98 93.3 
Complete RBBB 44 41.9 
Good biventricular function 104 99.1 
NYHA- I 97 92.4 
NYHA- II 7 6.7 
NYHA- IV 1 0.95 
Mitral regurgitation- I 68 64.8 
Mitral regurgitation- II 25 23.8 
Mitral regurgitation- III 3 2.9 
Mitral regurgitation- IV 1 0.95 
Tricuspid regurgitation- I 63 60 
Tricuspid regurgitation- II 7 6.7 
Tricuspid regurgitation- IV 1 0.95 
Residual small VSD (without shunt) 16 15.2 
Pulmonary regurgitation (I) 10 9.5 
Aortic regurgitation (I-II) 9 8.6 
Signs of pulmonary hypertension 2 1.9 
LVOTO (light obstruction) 2 1.9 
Incomplete RBBB 34 32.4 
Anticongestive therapy 21 20 
 
 
 
5.3.4. Follow- up therapy 
Anticongestive therapy was applicated in 21 patients (20%) during the follow- up. This 
included diuretics, ACE- inhibitors and B- blockers. This therapy was given to the patients 
with NYHA III-IV, or the patients with mitral and tricuspid regurgitation grade III-IV, or in 
the direct postoperative period. 
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     6. Discussion 
      6.1. Preoperative situation 
     6.1.1. Preoperative findings 
      In our retrospective study, we reviewed the biventricular repair of atrioventricular septal 
defects in both Down syndrome patients and non- Down syndrome patients. The key factor 
to proceed for biventricular repair is whether the ventricles are balanced or not. Both left 
and right AV valves may equally share the common AV valve orifice, this arrangement 
termed a balanced defect. But when the AV valve sits more over one ventricle than the 
other, the contralateral ventricle is typically hypoplastic. When the AV orifice favors the 
right AV valve (right dominance is existent), and when favors the left AV valve (left 
dominance is existent). The ventricular balance is based on the size of the ventricular inlet, 
not on the size of the ventricular chamber, and is assessed with echocardiography, on the 4- 
chamber view (46). This improvement in the understanding of morphologic anatomy, a 
considerable advance in surgical technique, more efficient myocardial protection and better 
postoperative care leads to a reduced mortality rate of less than 4% (3.6%) even in young 
children, as reported by Tweddell et al. (47) and by Dragulescu et al. (48). In addition to 
that the improved management of postoperative pulmonary artery hypertensive crisis using 
nitric oxide and pharmacologic resources decreased significantly the operative mortality. 
The main surgical techniques used to repair AVSD are two- patch technique as described 
by George Trusler in the article by Mills et al. (49) or single- patch technique as described 
by Rastelli et al. (41) depend on the morphologic anatomical findings intraoperatively. 
      We report on the experience of the Pediatric Heart Center, Giessen in the period from 1997 
to 2007, in which both two- patch and single- patch techniques were used for biventricular 
repair of AV septal defects. Only in 5 patients (4.5%) the diagnosis was performed 
prenatally. The others were diagnosed postnatally (95.5%) either during a routine 
echocardiography examination for patients with Down syndrome (67.3%) or they were 
presented with symptoms and signs of heart failure or accidentally during medical 
examination for respiratory infection. The clinical presentation of the patients with partial 
AVSD was late compared to the patients with complete AVSD because they were 
asymptomatic or had only mild symptoms. The operation date of the partial AVSD patients 
was also later. The patients with complete AVSD were presented in the clinic during the 
first months of life as a result of progressive heart failure (sweating, tachypnea, dyspnea 
and edema). Heart murmur was found in 100% of these patients, pulmonary hypertension 
in 62.7%, failure to thrive in 36.4%, cyanosis in 26.4%, and respiratory infection in 21.8%. 
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Down syndrome was associated with atrioventricular septal defect in 67.3% of our patients, 
Lange et al. reported 71.6% (50). Pulmonary hypertension was diagnosed in 62.7% of all 
our patients and in 75.6% of the patients with Down syndrome, similar to the reports by 
Chi et al. (51). Only 1 patient (1.4%) from Down syndrome group had severe left side AV 
valve insufficiency preoperatively, which was very low compared with the non- Down 
patients, in which 5 patients (13.9%) had severe MI. Lange et al. reported that Rastelli type 
B and C were more frequent in patients with Down syndrome (50), which we could not 
find. The combination with tetralogy of Fallot in our series was seen in 6 patients (5.5%), 
Studer et al. reported 6.5% (25), which was comparable. Regarding the population we 
studied, we must stress on the concept of an early surgical correction of AV septal defect 
before development of fixed pulmonary vascular resistance, which is suggested by Böning 
et al. (52) and by Lange et al. (50). The median age at operation for all patients was 7.2 
months in our patients and the mean age at operation was 1.9 ± 3.6 years. The patients in 
our study had a wide range of ages between 92 days and 19.8 years and this explains why 
the mean age at operation was more than 6 months. The median weight at operation was 
5.8 kg (range 3.4- 65 kg). Böning et al. (52) reported a median age of 1.2 years and a 
median weight of 7.6 kg. Backer et al. (53) reported a median age at operation of 8 months 
(range, 1 month- 108 months), while Moran et al. (54) reported a median age of 6 months. 
Yamaki et al. indicated that pulmonary vascular obstructive disease in patients with 
complete AVSD and Down syndrome may progress more rapidly than it does in non- 
Down syndrome patients (55). Therefore, in order to avoid progression to irreversible 
pulmonary vascular obstructive disease, surgical intervention before 4 months of life may 
be appropriate in Down syndrome patients, as suggested by Ando et al. (56). By comparing 
our results with the other studies and with taking into consideration, that the pulmonary 
vascular disease usually appears early in life and progresses rapidly especially in complete 
AV septal defects with large VSDs, it is our protocol to operate before the development of 
pulmonary vascular resistance, cardiomegaly and severe AV valve insufficiency (between 
4- 6 months). This wide range of operation ages in our patients was due to the patients with 
partial and or intermediate AV septal defects, who were operated later in their life (more 
than 6 months of age). 
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     6.1.2. Medical therapy (Anticongestive therapy) 
      Patients with partial AV septal defect who are presented with signs and symptoms similar 
to those with secundum ASD, as such rarely need medical therapy. They are operated later 
in their life. Some of them may be presented with signs and symptoms of congestive heart 
failure, as reported by Manning et al. (57). The patients with complete AV septal defect 
tend to develop symptoms and signs of congestive heart failure and pulmonary vascular 
obstructive disease as a result to large left to right shunt and associated AV valve 
regurgitation. They should undertake initial aggressive medical management to relieve the 
symptoms, as suggested by Driscoll et al. (58). An earlier intervention is indicated if 
medical management fails to stablize the patient. In 1985, Bull et al. (59) questioned the 
advisability of repairing complete AVSD in patients with Down syndrome, on the 
assumption that early repair carries a high risk for an uncertain prospect. They reported a 
survival of 80% at 15 years with medical management and recommended medical 
treatment, unless a unit can offer exceptional surgical results. In our series 70 patients 
needed anticogestive therapy before the surgical correction (63.6%) consisting mainly of 
diuretics, B- blockers, ACE inhibitors and digoxin. All those patients who required medical 
therapy before operation were patients with complete AV septal defect, with 52 patients 
(72.3%) from group D and 18 patients (50%) from group ND. The higher rate of medical 
therapy in group D compared to group ND is due to pulmonary hypertension, pulmonary 
congestion and respiratory infections. Our policy is early surgical repair of patients with 
complete AVSD and associated Down syndrome which is safe and accomplished with very 
low mortality rate and excellent short and long- term results. 
 
     6.1.3. Palliative procedures 
      The treatment of choice for an atrioventricular septal defect is primary surgical repair. The 
palliative procedures, like pulmonary artery banding for palliation of congestive heart 
failure have a very limited role in the treatment of AV septal defect. The indication for 
pulmonary artery banding are patients with AV septal defect with associated anomalies, 
preterm patients, severely unbalanced defects, or preparation for Fontan circulation and 
poor clinical condition due to comorbidity conditions precluding major surgical 
intervention. In our series, 10 patients underwent palliative procedures (9.1%), including 8 
pulmonary artery banding (7.3%) and 2 aorto- pulmonary shunt (1.8%), which is less than 
that found in the literature. Lange et al. reported 20% of patients with complete AV septal 
defect underwent palliative procedures (50) and Ando et al. reported 12% (56). All those 
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patients who underwent pulmonary artery banding had secondary pulmonary hypertension 
due to pulmonary overflow and 4 patients of them had unbalanced ventricles. In those who 
underwent aorto-pulmonary shunt, both of them had right ventricular outflow tract 
obstruction (Fallot tetralogy). This means that 90.9 % of our patients underwent primary 
repair (one stage repair) and palliative procedures were only done in preterm infants or in 
those who had coexisting cardiac anomalies or those who had comorbidities which were 
not feasible for primary repair. The median age at palliation procedures in our institute was 
3.7 months (range, 12 days- 6.9 years). The primary repair reduces residual lesions 
following correction, and may avoid problems related to delaying surgery such as 
development of fixed pulmonary vascular resistance, complications related to pulmonary 
artery banding or aorto- pulmonary shunt, a less complicated postoperative course and 
fewer repeat surgeries as suggested by Najm et al. (60) and McElhinney et al. (61). On the 
other hand staged treatment of AV septal defect remains a valid option and continues to be 
utilized as described by Silvermann et al. (62) and William et al. (63). 
 
6.1.4. Preoperative diagnosis 
The diagnosis of AV septal defect is usually based on clinical history, physical 
examination, ECG, chest radiogram, and echocardiography, which make the diagnosis in 
almost all cases certain. Shashi et al. reported that the diagnosis of complete AVSD in 
patients with Down syndrome can be done by physical examination and ECG in 78% of 
patients (64). Cardiac catheterization and cineangiogram are only required when major 
cardiac anomalies coexist and when the operability is questioned because of pulmonary 
vascular disease especially in Down syndrome patients as suggested by Soudon et al. (65). 
Kwiatkowska et al. (66) reported that echocardiography is usually sufficient for the full 
assessment of AVSD and the choice of further treatment. In our study, beside clinical 
history, physical examination, ECG, chest radiogram, in all patients echocardiography and 
color Doppler were used (100%) and cardiac catheterization was used in 79 patients 
(71.8%) which is relative more than other reports of many centers. This means that cardiac 
catheterization also was used for AV septal defect patients without coexisting cardiac 
anomalies and in whom the anatomy or physiology was unclear after an adequate 
echocardiogram. 
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6.2. Operative data 
6.2.1. Total bypass and aortic clamping time 
Many studies identified the CPB time as a predictive risk factor for postoperative mortality 
as suggested by Ando et al. (56). The CPB generally promotes an inflammatory reaction, 
therefore, an effort to minimize CPB time is another key to the reduction of postoperative 
morbidity and mortality. By contrast in the report of Alexi-Meshkivili et al. the procedural 
times were no risk factor for perioperative mortality (67). In our study the mean CPB and 
aortic cross clamping times for all patients were 150.9 ± 60.5 and 88.1 ± 35.4 min., 
respectively. The mean CPB and aortic clamping times were significant more in group D 
compared to group ND. The cause of that was that more patients in group D underwent 
two- patch technique (85.1%). Backer et al. reported that the mean CPB and ischemia times 
were 157 ± 37 min. and 123 ± 28 min., respectively (53). Ando et al. reported that the mean 
CPB and aortic clamping times were 123.6 ± 31.7 min. and 87.7 ± 23.6 min., respectively. 
In all patients of our study repair was performed using continuous extracorporeal 
circulation with mild to moderate hypothermia (pharyngeal temperature 31-32°C) and 
myocardial protection was provided with cold crystalloid cardioplegia ( Bretschneider). 
 
6.2.2. Operative technique 
Skillful surgical technique is an important factor in the biventricular repair of AVSD. Left 
ventricular size plays an important role in the postoperative course, as reported by Van 
Vida et al. (68). The volume of LV can be increased by precise sizing of the patch and the 
attachment of the ventricular septal patch a little more to the right of the ventricular crest. 
At the same time avoiding of the oversizing which results in patch redundancy with the 
potential for left AV valve insufficiency. The undersizing of the patch results in LVOTO. It 
is our policy to close the cleft of the left AV valve which is a controversial issue in several 
studies, because this may lead to left AV valve stenosis, which is suspected in 2 cases of 
our patients. This was corrected intraoperatively by the removal of cleft sutures. But at the 
same time, if this cleft is left open it leads to increased incidence of left AV valve 
insufficiency as suggested by Alexi et al. (67). The most important factor to improve leaflet 
coaptation is avoiding placement of sutures on the leaflet of left AV valve side during 
closure of ASD, by trying to place the suture more on the right side, thus increasing valve 
surface area and preventing leaflet puckering. Our biventricular repair of AVSD either by 
two- patch or by single- patch technique depends on the morphologic anatomical situation. 
If it is with two- patch technique (73.6%), it provides good access to the marging of the 
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VSD, thus allowing sufficient orientation to the LVOT, the aortic valve, and the conduction 
system. The same technique is suggested also by Alexi et al. (67). If  single- patch is used 
(26.4%) it involves direct closure of the ventricular element of the defect, thus avoiding the 
use of  a patch for the ventricular component, or direct suturing of the common AV valve 
leaflet to the crest of the ventricular septum, as proposed and reported by Wilcox et al. (69) 
and Nicholson- Nun (70) respectively. In most cases in our study (90%) we left the 
coronary sinus draining into the left atrium, in order to reduce the incidence of complete 
AV block.  
 
6.2.3. Intraoperative echocardiography 
The transesophageal or transthoracic echocardiography (if the infant is small) are of great 
help in the operating room to verify complete closure of the interatrial, interventricular 
communications and absence of important AV valve regurgitation or LVOTO. In our study 
all patients had intraoperative echocardiography, which was the key factor to remove the 
cleft suture from a left AV valve in 2 patients (1.8%) because of difficulty in weaning from 
HLM  due to a left AV valve stenosis. Kim et al. suggested that in a complete AVSD 
repair, intraoperative echocardiography did not show the same finding, as that of follow- up 
echocardiography in some cases (71). However, this discrepancy is not so great as to 
require reoperation in early to mid-term follow- up. Therefore, intraoperative 
echocardiography may be used as tool to predict durability of surgical results and to 
decrease the incidence of reoperation in complete atrioventricular septal defects. 
 
6.2.4. Intraoperative complications 
The AVSD repairs are associated with intraoperative complications, including rhythm 
disturbances, pulmonary hypertensive crisis, low cardiac output syndrome, difficult AV 
valve repair mainly of the left side, difficult weaning from HLM, and bleeding. In our 
study 13 patients had intraoperative pulmonary hypertensive crisis (11.8%), 10 patients  
(9.1%) had complete AV block grade III , 6 patients (5.5%) had weaning problems from 
HLM, due to different reasons for example, severe MI, or low cardiac output syndrome, 2 
patients (1.8%) had air embolism in coronary artery with ECG changes. Rhythm 
disturbances occurred in 6 patients (5.5%), that were mostly junctional ectopic rhyhm, 
supraventricular ectopic extrasystole, and sinus tachycardia. In 4 patients mitral valve 
repair was difficult (3.6%), due to severe dysplastic left AV valve, while tricuspid valve 
repair difficulty, protamine allergy, hemostasis difficulty, and LVOTO occurred in 1 
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patient each. There was 1 intraoperative death due to severe mitral insufficiency and 
pulmonary hypertensive crisis which lead to right heart dilatation with right heart failure 
(0.9%), which is very low compared to reports from Böning et al. in which the early 
mortality was (10.7%) (52). 
 
6.2.5. Thorax closure 
Primary chest closure is usually performed if the patient is hemodynamically stable after 
weaning from HLM. But sometimes open heart operations in children may lead to 
myocardial swelling and increasing lung water. Decreasing intrathoracic space may then 
make chest closure difficult. Delayed closure may be beneficial in this setting. Potential 
risks of delayed sternal closure are sepsis and sternal instability. In the reports from Iyer et 
al. the sternum was left open for 3.8 ± 0.29 days, and no patient required reexploration for 
mediastinitis and no patient had an unstable sternum (72). Six of our patients underwent 
secondary thorax closure (5.5%), the mean duration for secondary thorax closure was 3.8 ± 
1.8 days and the median was 3 days (range, 2- 7 days). The main reasons to leave the 
thorax open were hemodynamic instability, myocardial swelling or hemostasis difficulty. 
Four patients underwent operative revisions to be closed directly after revision; none of 
these patients died. The delayed chest closure using a pericardial membrane is a safe 
procedure in children with compromised cardiac output and myocardial swelling after 
AVSD repair avoiding cardiac tamponade. 
 
6.3. Postoperative course 
6.3.1. Postoperative need for catecholamine and diuresis therapy 
In the postoperative course, the catecholamine support therapy plays an important role in 
supporting the circulation, especially in patients who develop preoperatively or 
intraoperatively severe cardiopulmonary instability. The indications to use catecholamine 
are to stablize systemic blood pressure, to increase cardiac output or to increase peripheral 
vascular resistance after weaning from HLM intraoperatively or postoperatively in the 
intensive care unit especially following long CPB and aortic clamping times. 
Catecholamines can be used with nitroglycerine to reduce preload. Norepinephrine was 
used to reduce postoperative volume needs and consequentlly edema development while 
nitroglycerine was used in low doses to reduce coronary spasm. The use of 
phosphodiesterase-3- inhibitors like milrinone® as an inodilatator leads to a reduction in 
the use of catecholamine as inotropes. Alexi- Meskishvilli et al. (67) reported the need for 
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use catecholamine in the postoperative period especially in patients with preoperative 
severe cardiopulmonary instability or difficult intraoperative repair of dysplastic AV valve. 
In our patients, catecholamines were used intraoperatively and postoperatively in 75.2%. 
The mean duration for catecholamine therapy was 3.3 ± 4.5 days and the median duration 
was 2 days (range, 0- 34 days). The use of catecholamine was significantly higher in group 
ND patients compared to group D patients because of the complicated postoperative course 
of the ND patients. Generally almost all patients required diuretics therapy after AVSD 
repair, due to the effects of CPB on renal function and interstitial fluid distribution. A long 
period of CPB increases the risk of acute renal failure and volume overload. All patients in 
our study received in the postoperative period loop diuretics like, lasix® and dopamine 
agonists to reduce the volume overload especially in the lungs. 
 
6.3.2. Postoperative pulmonary hypertensive crisis 
This serious syndrome of hyperacute rise in pulmonary artery pressure is usually 
accompanied by brochospasm, often followed within seconds, or accompanied by profound 
reduction in cardiac output and fall in arterial oxygen saturation. This usually occurs in 
infants who are intubated after AVSD repair. The crisis may appear spontaneously, but 
usually occurs during or shortly after suctioning of the endotracheal tube. The prevalence is 
more after 18 hours after operation, but it can occur before or after that time. During an 
acute hypertensive crisis, atypical cardiac tamponade can result from acute right ventricular 
dilatation as reported by Atsumi et al. (73). Lindberg et al. (74) reported that the incidence 
of pulmonary hypertensive crisis in the postoperative period was 14%. In our study, 48 
patients (44%) had pulmonary hypertensive crisis in the postoperative period. All of them 
had satisfactory response to therapy, which included deep sedation, increased inspired 
oxygen concentration, vasodilators use like nitroprusside, flolan®, ilomedin® and nitric 
oxide. The mean duration of therapy was 5.6 ± 3.5 days, and the median duration was 5 
days (range, 1- 14 days). Preoperatively there were 69 patients with pulmonary 
hypertension. It should be noted that more patients in group D (52.7%) had pulmonary 
hypertensive crisis compared to group ND (25.7%), but the mean duration of crisis therapy 
was significantly less in D group compared to ND group ( 5.2 ± 2.9 days and 7.1 ± 5.3 
days, respectively). Only 10 patients were discharged with persistent pulmonary 
hypertension (9.2%). This indicates the effectiveness of preventive measures used in our 
ICU by maintenance of paralysis and sedation for at least 24 hours and for at least another 
24 hours if the patient remains intubated. Unnecessary suction of the endotracheal tube 
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especially in patients who are known to have pulmonary hypertension  should be avoided. 
The dosage of catecholeamine should be reduced if the patient´s hemodynamic situation 
allows it. Postoperative pulmonary hypertensive crisis is common after a complete AVSD 
repair and in most cases can be managed successfully with conventional treatment and has 
a favourable postoperative outcome.  
 
6.3.3. Mechanical ventilation and Intensive care unit stay 
In general, extubation is best performed, when the patient is hemodynamically stable, with 
enough oxygenation, and there is no contraindication for extubation. The mean intubation 
time reported by Böning et al. (52) was 5.0 ± 5 .1 days, and the median was 2.5 days, while 
the mean ICU stay was 5.0 ± 3.8 days. 
The mean intubation time in our study was 3.5 ± 4.8 days, and the median was 2.5 days    
(range, 0- 39 days). The mean ICU time was 6.4 ± 7.3 days, and the median was 6 days 
(range, 0- 71 days). There was no significant difference in the mechanical ventilation time 
and ICU stay between group D and group ND. The longest intubation time and longest ICU 
stay was in one patient from group ND, who had a complicated operative and postoperative 
course, and underwent heart transplantation later. We could not find a correlation between 
long CPB and aortic clamping time on the one hand and the intubation and ICU time on the 
other hand, because some patients who had long CPB and ischemia times, had short 
intubation and ICU times. Neirotti et al. suggested early extubation within 6 hours 
postoperatively (75), because some of the problems following surgery are related to the 
endotracheal tube and mechanical ventilation and the interventions necessary to maintain 
them. Even they also reported, that early extubation is not feasible in all patients. Ito et al. 
suggested the use of continuous positive airway pressure in the postextubation period 
especially for Down´s patients because of higher tendency to develop stridor (76). In our 
study, the incidence of stridor was higher in group D patients (28.4%) compared to group 
ND (11.4%), with the use of continuous positive airway pressure in all these patients. 
 
6.3.4. Postoperative complications 
A clinical condition of fluid retention and generalized edema is common in infants after 
major cardiosurgical interventions. CPB contributes to the development of many adverse 
effects like acute renal injury, which leads to fluid retention and global heart insufficiency 
with edema. Surgery can be the primary cause of chylothorax due to injury of the thoracic 
duct, hemorrhagic pleural effusion, and pneumothorax. The other complications are 
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associated with bacterial infections for example, respiratory infections, sepsis, or wound 
infection. In our study, early after surgery, 32 patients (29.4%) had respiratory infections, 
28 patients (25.7%) had pleural effusion, 26 patients (23.9%) had atelectasis, 25 patients 
(22.9%) had stridor, 15 patients (13.8%) had pericardial effusion, 6 patients (5.5%) had 
complete AV-block, 5 patients (4.6%) had lung edema, 3 patients (2.8%) had circulatory 
collapse with need for resuscitation, 2 patients (1.8%) had bleeding, 2 patients (1.8%) had 
sepsis, 1 patient (0.9%) had renal dysfunction, 1 patient (0.9%) had temporary neurological 
deficit. Most of these complications were treated medically and some of them required 
surgical intervention, for example, 3 times pleural effusion draining, 2 times rethoracotomy 
for pericardial effusion and tamponade, and 6 times permanent pacemaker implantations. 
Böning et al. (52) reported postoperative complications like: infections (27.7%), complete 
AV-block III (29.8%), pleural effusion (14.1%), pericardial effusion (18.2%), renal 
dysfunction (7.6%), cardiac insufficiency (17.7%). The high incidence of respiratory 
infection and stridor in the postoperative period in our study, are attributed to that, that 
many of these patients are Down´s patients with pulmonary hypertensive crisis. 
Interestingly our patients tended to had a very low incidence of renal dysfunction and 
neurologic deficits (less than 1%) probably due to the fact that in our center inotropes and 
vasopressors doses are targeted to maintain enough cardiac output and arterial pressure 
direct in the operation room and in the postoperative period in the ICU as well as 
intraoperative myocardial and brain protection. None of our patients had wound healing 
problems, which are the same findings in the literature, as reported by Iyer et al. (72). Ando 
et al. (56) reported 2% wound infections and dehiscence. Apart from minor rhythm 
disturbances, like SVES, JET, VES, which were temporary in the postoperative period, 
only 3 patients were discharged with JET, major rhythm disturbances like complete AV-
block were found in 6 patients who underwent permanent pacemaker implantation (5.5%). 
When comparing Down patients with non- Down patients, we recognized that Down 
patients had more respiratory complications and less complete AV block than non- Down 
patients. 
 
6.3.5. AV valve function after AVSD repair 
AV valve insufficiency is common in patients with AVSD as well as after the surgical 
repair. Only 6 of our patients had preoperatively severe mitral valve insufficiency, 1 of 
them was a Down syndrome patient and the remaining patients had trivial or mild mitral 
insufficiency. The same findings were also reported by Lange et al. (50). Studer et al. (25) 
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reported that preoperative AV valve insufficiency was a risk factor for reoperation. Alexi-
Meskishvilli et al. (67) found an incidence of more complicated left AV valve anomalies of 
patients with Down syndrome compared with those without. In our study, the patients with 
non- Down syndrome presented a significantly higher incidence of left AV valve anomalies 
(dysplastic valve), and this result is compatible the findings of other authors (77). In all of 
our patients mitral valve cleft was closed, but in 2 patients intraoperatively, the cleft sutures 
were removed because the mitral side of AV valve was small. This is comparable with 
reports from Alexi-Meskishvili et al. (67) and Günther et al. (78).  
Marino (79), stated that Rastelli type C is more prevalent in patients with Down syndrome, 
Lange et al. (50) reported that Rastelli type B and C are more prevalent in Down patients. 
Both findings we could not confirm in our study because more than 80% of our patients 
showed Rastelli type A. In the direct postoperative period, 4 patients with severe mitral 
valve insufficiency underwent surgical revisions, this included 3 cases of mitral valve 
repair and 1 case of mitral valve replacement, because of impossible repair. In the control 
echocardiography, postoperatively and before discharge, there were 7 patients with 
moderate to severe mitral valve insufficiency grade III (6.4%), 2 patients of them had 
preoperatively severe mitral insufficiency, all of them underwent two- patch technique 
repair and 4 of them were Down patients. At the same time 75 patients had no or trivial 
mitral valve insufficiency (68.8%), and 27 patients had mitral insufficiency grade II 
(24.8%). This means that 102 patients had no or trivial to mild mitral insufficiency 
(93.6%). We could not identify the Down syndrome as a risk factor for mitral valve 
insufficiency postoperatively. In the last echocardiography control during the follow- up 
period, 101 patients (96.2%) had no or trivial to mild mitral valve insufficiency, while 4 
patients had moderate to severe mitral valve insufficiency (3.8%). Two patients of each 
group had severe MI. This is comparable with the reports from Böning et al. (52) and 
Bando et al. (80) (93.9% and 94%, respectively, absent and mild MV insufficiency), but 
better than that reported by Weintraub et al. (81) and Wetter et al. (82) (84% and 78%, 
respectively, absent and mild MV insufficiency after surgery). In our patients, in the time 
between the first control before discharge and the last control during follow- up, 17 patients 
underwent reoperations on mitral valve, including 12 times mitral valve repair and 6 times 
mitral valve replacements. Only 2 patients in the following- up period showed deterioration 
of the mitral valve insufficiency from garde II to grade III-IV, taking into consideration that 
all patients except 2 patients in our study underwent mitral valve cleft closure. One  patient 
from those patients in whom the mitral cleft left unsutured, underwent later on mitral valve 
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replacement. Wetter et al. (82) reported an increase in the degree of valve insuffuciency 
postoperatively in 15%, predominantly in patients without cleft closure. There was no 
correlationship between the existance of a preoperative AV valve insufficiency and the 
amount of mitral insufficiency in the postoperative period or at the last follow- up, as 
reported also by Böning et al. (52) and Weinraub et al. (81).  
 
6.3.6. Left ventricular outflow obstruction 
Differences exist regarding the association between left AV valve insufficiency and the 
presence of left ventricular outflow obstruction, as reported by Marino and de Biase 
(79;83). In the unoperated patients the incidence of important LV outflow tract obstruction 
in all types of AVSD is very small, about 1% of cases is reported by Studer et al. (25). On 
the other hand, the LV outflow tract obstruction becomes often apparent as a postoperative 
complication as suggested by Piccoli et al. (84). 
In our series, none of the patients had preoperatively LVOTO, but in the direct 
postoperative period, 1 patient underwent surgical revision in the fourth postoperative day 
due to narrowing of the left ventricular outflow tract by the VSD patch. The same patient 
required reintervention for the same reason after 63 days. After that the patient was free 
from any obstruction. During the follow- up, only 5 patients (4.8%) underwent reoperations 
for LVOTO, 4 of them had discrete subaortic stenosis due to acquired fibromusclar ridge, 
which was resected. In the last control during the follow- up, 2 patients (1.9%) had light 
LVOTO (pressure gradient less than 25 mmHg). We did not classify this subaortic LVOTO 
as a complication related to the surgical procedure since the appearance of this subaortic 
membrane is an independent factor related to the treatment of the long, narrow LV outflow 
tract, which is common in patients with complete AVSD. 
 
6.3.7. Complete AV- block and pacemaker implantation 
This surgical technique related variable can be considered to occur more frequently in 
complex malformations, but since Lev described the conduction system in AVSD defects 
in 1958, the prevalence of surgically induced complete AV block has been reduced to about 
1% as reported by Lev et al. (7). In our series 6 patients (5.5%) required implantation of 
permanent pacemaker postoperatively. During the follow- up control, 3 patients underwent 
pacemaker explantation (2 patients recovered and had sinus rhythm, and 1 patient had heart 
transplantation), and another 3 patients required permanent pacemaker implantation, so that 
at the last follow- up control, there were 6 patients (5.7%) with permanent pacemaker due 
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to complete AV- block. Böning et al reported 7.4% (52). The tendency for pacemaker 
implantation was significantly higher in group ND (14.3%) compared with group D 
(1.4%). Lange et al. (50) reported that 5.1% of Down patients and 6.3% of non- Down 
patients required permanent pacemaker. There was no death of the patients who had a 
permanent pacemaker in our study. In the last follow- up control, 98 patients (93.3%) were 
in sinus rhythm without any other rhythm disturbances and 1 patient (0.95%) with JET 
with 92% freedom from pacemaker implantation after 10 years. Backer et al. (85) reported 
3.5% of his patients required permanent pacemaker due to heart block.  
 
6.3.8. Right ventricular outflow obstruction 
In our study 6 patients (5.5%) were associated with right ventricular outflow tract 
obstruction (Fallot tetralogy). All of them underwent two- patch technique repair, and in 
addition to that, 1 patient required a Contegra graft, 1 patient required pulmonary 
valvotomy, 2 patients required only infundibular muscular resection, and 2 patients 
required a ventriculotomy plus infundibular muscular resection and a transannular patch 
enlargement. When compared to the other 104 patients, these 6 patients did not present 
worse results with respect to reoperation. There is a trend for these patients to be operated 
on later than those with AVSD alone. RVOTO in these patients prevents the development 
of pulmonary hypertension and enables surgery to be delayed. In the last follow- up only 2 
patients had pulmonary insufficiency grade I-II, which is common in transannular patch 
repair. Only 2 patients (33.3%) underwent a pulmonary systemic shunt before the primary 
repair. In our center primary repair in these patients, whenever possible was given the 
preference, because the early palliative not only adds an inherent mortality, but also tends 
to make definitive repair more difficult without offering any mortality benefits as suggested 
by Najm et al. (86). 
 
6.3.9. Medical therapy at discharge 
The need for medical therapy in the postoperative period for patients with AVSD included 
antiarrhythmic and anticongestive therapy, for example, Diuretics, B- blockers, ACE 
inhibitors, digitalis, and amiodarone® in order to bring cardiac performance to an adequate 
level by reducing afterload, preload and controlling rhythm disturbances. These drugs are 
used mainly in ICU and continuous in normal station, till the patients clinical condition 
stablized. Many of these drugs were reduced or stopped before the patients were discharged 
from hospital but some patients were discharged from the hospital under this treatment to 
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be stopped after the first follow- up control, 2 weeks after discharge. In our series 66 
patients (60.6%) were discharged under diuretics, digitalis, ACE-I, and B-blockers therapy, 
this included the patients with moderate to severe mitral insufficiency and the patients with 
persistent pulmonary hypertension. In group D 70.3% of patients were discharged on 
medical therapy and in group ND 40% of patients were discharged on medical therapy. In 
all patients, 55 patients (50.5%) with diuretics, 32 patients (29.4%) with ACE-I, 15 patients 
(13.8%) with digitalis, 10 patients (9.2%) with B-blockers, and 10 patients (9.2%) with 
sildenafil, ilomedin. The therapy protocol of our patients with AVSD after repair and at 
discharge was the same as reported by other literature (Monteiro et al. (87)). 
In our study, 94 patients (86.2%) were discharged to their home because of stable clinical 
condition and 15 patients (13.8%) to the referring hospital under medical therapy and to be 
under medical observation. 
 
6.3.10. Survival and mortality 
The natural history of complete AVSD was very poor because of early progression of 
obstructive pulmonary vascular disease (88). The hospital mortality after repair of AVSD is 
generally reduced in recent years to less than 4% as reported by Tweddell et al. (47). This 
is achieved by improved understanding of the morphology of this complex malformation, 
better surgical techniques, general improvements in cardiac surgery in infants, and also 
improved physiological control during extracorporeal circulation, more efficient 
myocardial protection and better postoperative care in the treatment of pulmonary 
hypertensive crisis. Due to these improvements, many factors which were recognized as a 
risk factor for mortality are now neutralized, like young age, Down syndrome, and major 
associated cardiac anomalies, but some factors, like severe preoperative NYHA functional 
class, accessory valve orifice (double-orifice left AV valve), and severe preoperative AV 
valve regurgitation still represent elevated risk for mortality after AVSD repair. In our 
series we could not identify the risk factors for mortality, this is because only 1 patient 
(0.9%) in our series, died intraoperatively. The cause of death was severe mitral valve 
regurgitation which was difficult to repair and pulmonary hypertensive crisis which lead to 
right ventricular dilatation and right heart failure. This patient could not be weaned from 
the cardiopulmonary bypass. She was less than 4 months of age at operation, less than 4 kg 
weight, had preoperatively pulmonary hypertension, and was on anticongestive therapy. 
The patient had no associated cardiac anomalies, preoperatively AV valve insufficiency 
grade I-II, and she was a non- Down syndrome patient. The only risk factor in this patient 
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was preoperative pulmonary hypertension. Böning et al. (52) reported that preoperative 
pulmonary hypertension was a risk factor for early mortality and recommended early 
surgical repair of AVSD, as delayed timing of surgery rather results in further elevation of 
pulmonary vascular resistance and fixed pulmonary hypertension. He reported also that the 
diagnosis of a complete AVSD, ECC more than 110 minutes, two- patch technique and 
ommittance of cleft closure as a specific risk factors for mortality. In our study 73.6 % of 
patients underwent two- patch technique, 67.3% were associated with Down syndrome, 
62.7% had preoperatively pulmonary hypertension, 5.5% had severe mitral valve 
insufficiency preoperatively, and the early mortality was less than 1%, and no late death 
(the probability of survival after 10 years was almost 100%). These results compare 
favourably with other studies, for example, Tlaskal et al. (89) and Litwin et al. (90). There 
are some arguments about the impact of Down syndrome on the the early and late 
outcomes of surgical repair of complete AVSD. Yamaki et al. (55) and Clapp et al. (91) 
reported that Down syndrome was a risk factor for rapid progression of obstructive 
pulmonary vascular disease. Morris et al. (21) reported that Down syndrome might be 
associated with high perioperative mortality compared to non- Down patients because of 
associated pulmonary vascular disease. The same less favourable results were also reported 
by Studer et al. and Pozzi et al. (25;92). But on the other side Rizzoli et al. (93) reported 
that Down syndrome was not an independent risk factor for operative mortality and the 
patients with Down syndrome underwent fewer reoperations. Many of the recent reports 
from Tweddell et al., Al-Hay et al., Günther et al., Bando et al., Najm et al. and Prifti et al. 
using multivariate analysis failed to indicate a presence of Down syndrome as a predictor 
for operative mortality (47;77;78;80;86;94). Bull et al. (59) assumed that surgical repair of 
complete AVSD in children with Down syndrome carries a high risk and recommended 
medical treatment, unless a unit can offer exceptional surgical results. In our study the 
long- term survival in those with and without Down syndrome was similar. Down 
syndrome does not have an impact on the long-term survival of surgically operated 
patients, at least when the defect is repaired during the first year of life, as reported also by 
Masuda et al. (95). We conclude, that biventricular repair whether by two- patch or single- 
patch techniques for treating AVSD is effective, safe, associated with low mortality rate 
and the associated Fallot tetralogy and Down syndrome did not increase mortality or 
reoperation rate.  
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6.3.11. The need for reoperations 
The follow- up was possible for 105 patients (96.3%) in our series, Böning et al. reported 
94.8% follow- up completeness (52). The first follow- up usually 2 weeks after correction, 
then after 1, 3, 6 months examinations in the first year after operation, and then every year, 
Paulsen et al. suggested the follow- up every year or every second year (96). Although 
reoperation within 30 days postoperatively may contribute to a better long- term outcome, 
in general the most common causes for reoperation are severe mitral insufficiency, 
subaortic obstruction, pacemker implantation, and residual VSD closure, and these are 
associated with added risk of death. In our study reoperations were necessary in 23/105 
patients (21.9%). In the patient group analyzed by Böning, the reoperations were necessary 
in 14% of patients (52). In our study 5 patients (4.5%) underwent revisions in the direct 
postoperative period, this included 3 mitral valve repairs (1 patient later on had MV 
replacement and another one patient had heart transplantation), 1 mitral valve replacement 
(this later on underwent heart transplantation), and 1 LVOTO reconstruction (this patient 
underwent re-revision later on). During follow- up there were 9 mitral valve repairs, 5 
mitral valve replacements (1 had early MV repair), 6 LVOTO repairs (in 5 patients), 2 
heart transplantations (1 had early MV replacement and 1 had MV repair previously), 1 
VSD occluder implantation, and 1 PDA coil closure. Total MV replacements were 6 times, 
MV repairs were 12 times, LVOTO repairs were 7 times, with the tendency for reoperation 
more in group ND. None of the patients with partial AVSD underwent reoperation, and 
only 9 patients (12.2%) with Down syndrome had reoperation (3 cases MV repairs, 2 cases 
MV replacements, and 4 cases LVOTO repairs). In group ND 14 patients (41.2%) 
underwent reoperation. Lange et al. (50) reported that 11.1% of Down´s patients required 
reoperation and 22.7% of non- Down´s patients required reoperations, which is comparable 
with group D in our results, but in group ND their results were very low than our results. 
The overall freedom from reoperation at 10 years in our series was 80% of patients, 
freedom from MV repair was 87%, freedom from MV replacement 95%, and pacemaker 
implantation 92%, while the freedom from LVOTO repair at 10 years was 88%. The 
overall freedom from reoperations is comparable to that reported by Böning et al. (52) with 
78.6% at 10 years and to that reported by Pozzi et al. (92) with 84.2%. We notice from our 
results, that patients with Down syndrome have lower incidence of reoperation for mitral 
valve insufficiency compared to patients without Down syndrome, presumably because 
severe mitral valve anomalies were less prevalent in patients with Down syndrome (only 1 
patient in our study in D group had preoperatively severe mitral regurgitation). Formigari et 
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al. (97) also reported a higher incidence of subaortic stenosis in children with non- Down 
syndrome. In our study only 5 patients required reoperation (total reoperations = 7) for 
subaortic obstruction, 3 patients were associated with Down syndrome (4.2%) and 2 
patients were not associated with Down syndrome (5.9%). The overall freedom from any 
redo in Down syndrome patients at 10 years was 90%, while the overall freedom from any 
redo by non- Down syndrome patients at 10 years was 50%. This data show that the non- 
Down syndrome patients had a significant higher rate of reoperations compared to Down 
syndrome patients, which means that the children with normal chromosomal pattern are at 
increased risk for reoperations more than Down syndrome patients, which has been already 
reported by Al-Hay et al., Weintraub et al. and Formigari et al. (77;81;97). 
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    7. Summary / Zusammenfassung 
    7.1. Summary 
     The atrioventricular septal defect is a rare congenital malformation of the heart. The 
prevalence is 3-4% of all congenital cardiac malformation. Congenital heart disease has an 
incidence between 33 and 48% in Down syndrome, and AVSD is the most common heart 
defect (15-20%). The natural history of surgically untreated AVSD patients depends on 
morphologic and functional details of their malformation. The natural history for patients 
with a partial AV septal defect with mild left AV valve insufficiency is better than that with 
moderate to severe left AV valve insufficiency, but both of them have a very better natural 
history than those with a complete AV septal defect, in which the natural history is 
unfavourable. There is more than one strategy suggested for repair of AVSD (matter of 
controversy), depending on the ventricular balance (dominance). Univentricular palliation 
is mostly performed to correct severely unbalanced complete AVSD with hypoplastic left 
ventricle or other functional single ventricle, while biventricular repair, if feasible, remains 
a satisfactory option and the treatment of choice. Two techniques are widely used in the 
repair of  complete AVSD, namely a single- patch technique and two- patch technique. We 
reviewed the records of 110 patients with AVSD (74 with Down syndrome and 36 
without), who underwent a biventricular repair between January 1997 and December 2007. 
      In all patients preoperative, intraoperative and postoperative data including the long-term 
follow-up were recorded. Preoperative data included clinical course, diagnostic and 
palliative therapy. Intraoperative data recorded total cardiopulmonary bypass and aortic 
cross clamping times, delayed sternal closure and intaoperative complications. 
Postoperative data included duration of catecholamines and postoperative hypertensive 
crisis therapy, length of mechanical ventilation support and intensive care unit stay. These 
data were taken as the major factors influencing the postoperaive course. In the long-term 
follow- up all records including, physical examination, echocardiography, 
electrocardiogaphy, and cardiac catheterization results were evaluated. 
      The following results could be identified: 
- The patients with complete AVSD were presented at an earlier age than patients 
with partial AVSD and 63.6% of them were under anticongestive therapy. 
- All patients presented with heart murmur, while 67.3% of patients presented 
with signs and symptoms of congestive heart failure, 36.4% of patients 
presented with failure to thrive, 26.4% of patients with cyanosis and  21.8% of 
patients with respiratory infections.  
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- The patients who presented with pulmonary hypertension were 62.7% in our 
series, all of them were patients with complete AVSD. 
- Down syndrome patients represented 67.3% of all patients, and 75.6% of the 
Down syndrome patients had pulmonary hypertension. 
- The patients with severe mitral valve insufficiency preoperatively represented 
only 5.5% of all patients and 1.4% of all Down syndrome patients. 
- The patients with associated Fallot tetralogy represented 5.5% of all patients 
and 2 patients of them had aorto- pulmonary palliative shunt. 
- Only 9.1% of all patients (n = 10) underwent palliative procedures (pulmonary 
artery banding and aorto- pulmonary shunt), and none of them died. 
- Two- patch technique was done in 73.6% of all patients (n = 81), while single- 
patch technique was done in 26.4% of all patients (n = 29). 
- The overall early mortality was less than 1% (0.91%), with no late mortality, the 
cause of death was right heart failure due to pulmonary hypertensive crisis and 
severe mitral valve insufficiency. 
- The total CPB and aortic clamping times were comparable to other studies. 
- The postoperative course was uncomplicated in 73.4% of 109 living patients, 
and complicated in 26.6% of patients, mostly due to pulmonary hypertensive 
crisis (44%) and respiratory problems (29.4%). 
- Most of the postoperative complications were well controlled under 
conventional medical therapy. 
- Reoperation rate was 21.9% of the patients, within the follow- up period (total 
reoperations number = 29), most of these reoperations, were due to mitral valve 
insufficiency (12 MV repairs, 6 MV replacements), while the others included, 7 
LVOTO repairs, 2 heart transplantations, 1 VSD occluder implantation, and 1 
PDA coil closure. 
- The freedom from any reoperation at 10 years was 80% of all patients, the 
freedom from MV repairs was 87%, the freedom from MV replacements was 
95%, and the freedom from pacemaker implantations was 92%, while the 
freedom from LVOTO repair at 10 years was 88%. By Down´s patients the 
freedom from any redo at 10 years was 90%, while by non- Down´s patients at 
10 years it was 50%. 
- The patients who required permanent pacemaker implantations were 9 patients  
(8.2%), 3 patients of them underwent pacemaker explantation due to sinus 
 69
rhythm recovery (n = 2) and heart transplantation (n = 1). The freedom from 
pacemaker implantation at 10 years was 92%. 
- During the follow- up period 93.3% of the patients showed a normal sinus 
rhythm. Six patients had permanent pacemaker (5.7%), 1 patient had junctional 
ectopic rhythm (0.95%), and 44 patients had complete RBBB (41.9%). 
- In follow- up most of the patients were in functional status NYHA-I (92.4%), 
and in echocardiography examination, 101of the patients (96.2%) had no or 
mild mitral regurgitation, 4 patients (3.8%) had severe mitral insufficiency (2 of 
them are Down patients), and only 2 patients still had pulmonary hypertension 
(1 is Down syndrome patient).  
- Only a small number of patients was postoperatively investigated by cardiac 
catheterization, most of them for pulmonary hypertension follow- up.     
  
    According to these results the following conclusions could be drawn: 
- The biventricular repair of atrioventricular septal defects can be performed with 
good outcomes, a low mortality rate and primary repair is the treatment of 
choice and can be accomplished with good results. 
- The age at surgical correction should be as early as possible and before 6 
months of life particularly in Down syndrome patients to avoid the development 
of irreversible pulmonary vascular obstructive diseases and to avoid progressive 
ventricular dilatation from volume overload with progressive AV valve annular 
dilatation. 
- Down syndrome is not a contraindication to surgical repair because Down 
syndrome is not a risk factor for operative death in recent era. 
- Almost all AVSD can be adequately and sufficiently diagnosed by 
echocardiography, and it should be preferred to preoperative cardiac 
catheterization. An exception is in cases, in which AVSD associated with major 
cardiac anomalies or the morphologic anatomy not clear by echocardiography. 
- The duration of the total CPB and aortic cross clamping is not associated with 
an increased morbidity or mortality. 
- In long-term follow- up, the biventricular repair of AVSD even with small LV 
in our series are deemed satisfactory as evidenced by very low early mortality, 
absence of late mortality, and relative low incidence of reoperation. 
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- The reconstructed atrioventricular valve shows a good and long-lasting 
performance without an increase in late mortality or morbidity and the patients 
with Down syndrome had a lower incidence of any redo or mitral valve 
insufficiency reoperations compared with non- Down patients. 
 
      7.2. Zusammenfassung 
Der Atrioventrikuläre Septum Defekt ist eine seltene, angeborene Fehlbildung des              
Herzens. In 3-4% aller angeborener Herzfehler findet sich eine AVSD. In 33-48% aller 
Down Syndrom- Patienten findet sich eine angeborene Herzfehlbildung und am 
häufigsten ein AVSD. Die Prognose und das Ausmaß der pathophysiologischen 
Beeinträchtigung hängen überwiegend vom Ausmaß der drei Komponenten des Defekts 
ab: atrialem Defekt, ventriculärem Defekt und AV-Klappeninsuffizienz. Bei Vorliegen 
eines partiellen AV-Kanal ist die Prognose vor allem durch das Ausmaß des Shuntflusses 
und eventuell zusätzlich vorhandene Vitien beeinträchtigt. Beim kompletten AV-Kanal 
kann bereits im frühen Säuglingsalter eine schwere Herzinsuffizienz das Überleben 
infrage stellen. Die Wahl des Zeitpunktes für Korrektur hängt von der Schwere der 
hämodynamischen Beeinträchtigung ab. Üblicherweise wird primäre Korrektur angestrebt 
(Ein-/ Zwei- Flicken Technik), in seltenen Ausnahmefällen ist ein Banding des Truncus 
pulmonalis sinnvoll, wenn Zweifel bezüglich einer möglichen Imbalance der Ventrikel 
bestehen. In unserer retrospektiven Studie wurden insgesamt 110 Patienten mit AVSD 
untersucht, bei denen zwischen Januar 1997 und Dezember 2007 eine AVSD Korrektur 
durchgeführt wurde.  
Bei allen Kindern wurden die präoperativen, intraoperativen und postoperativen Daten 
einschließlich des Langzeitverlaufs erfasst. Im Rahmen der präoperativen Datenerhebung 
wurde der klinische Verlauf und die diagnostischen Methoden berücksichtigt. Als 
intraperative Daten wurde die Bypassdauer und Ischämiezeit, der Zeitpunkt des 
Thoraxverschluß und intraoperative Komplikationen erfasst. Im postoperativen Verlauf 
wurden Dauer der Katecholamintherapie, Dauer der postoperativen Behandlung 
pulmonalhypertensiver Krisen, die Beatmungsdauer und die Verweildauer auf der 
Intensivstation als wesentliche Merkmale für den unmittelbar postoperativen Verlauf 
herangezogen. Im Rahmen der Langzeituntersuchung wurden elektrokardiographische, 
echokardiographische Befunde sowie Herzkatheter- Befunde untersucht. 
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Wir kamen zu folgenden Ergebnissen: 
- Bei Patienten mit komplettem AVSD konnte die Diagnose deutlich früher als bei 
den Patienten mit partiellem AVSD gestellt werden und 63.6% der Patienten 
wurden antikongestiv behandelt. 
- Bei allen Patienten wurde ein Herzgeräusch angegeben, bei 67.3% der Fälle wurde 
der Herzfehler diagnostiziert, bei 62.7% der Patienten wurde pulmonale 
Hypertonie diagnostiziert, bei 36.4% wurde schlechtes Gedeihen angegeben, bei 
26.4% Zyanose und bei 21.8% wurde Atemwegsinfektionen angegeben. 
- In 67.3% der Patienten fand sich assoziiert ein Down Syndrom und in 5.5% eine 
assoziierte Fallot-Tetralogie. 
- In 5.5% der Fälle fand sich eine höhergradige Insuffizienz der Mitralklappe. 
- Insgesamt erfolgten 10 palliative Operationen (8 x Banding des Truncus 
pulmonalis und 2 x ein aortopulmonaler Shunt) (9.1%). 
- In  73.6% der Fälle wurde eine Zwei- Patch- Technik durchgeführt und in 26.4% 
der Fälle wurde eine Ein- Patch- Technik durchgeführt. 
- Die Frühmortalität im gesamten Kollektiv betrug 0.91%, die Spätmortalität 0%. 
- In unserem Patientenkollektiv die Bypassdauer und Ischämiezeiten sind mit der  
Literatur vergleichbar. 
- Schwerwiegende Komplikationen traten im postoperativen Verlauf selten auf 
(26.6%) und in die meisten Fälle waren pulmonal-hypertensive Krisen (44%) und 
pulmonalen Infektionen (29.4%), die mit mit einer medikamentösen Therapie gut 
kontrolliert werden konnten. 
- Die Reoperationsrate betrug 21.9%. 
- Die Wahrscheinlichkeit für ein reoperationsfreies Überleben lag bei 80% nach 10 
Jahren. Die Wahrscheinlichkeit für ein MK- Rekonstruktionsfreies Überleben lag 
bei 87%, MV Ersatz bei 95% und LVOTO Rekonstruktion bei 88% nach 10 
Jahren. 
- Die Wahrscheinlichkeit für ein schrittmacherfreies Überleben lag bei 92% nach 10 
Jahren. Bei 93.3% der nachuntersuchten Patienten lag ein normaler Sinusrhythmus 
vor (Schrittmacherversorgter AV-Block 3.Grades: 6/105 Patienten).  
- Die Wahrscheinlichkeit für ein reoperationsfreies Überleben lag bei 90% bei 
Patienten mit Down Syndrom und bei 50% in nicht- Down Syndrom Patienten 
nach 10 Jahren. 
 72
- Die 10- Jahres-Überlebenswahrscheinlichkeit war bei allen Patienten sehr gut (bei 
fast 100%). 
- Das funktionelle Ergebnis war nach AVSD Korrektur sehr gut (92.4% der 
Patienten befanden sich in NYHA-Stadium I), in der Echokardiographie wurde nur 
bei 3.8% der Patienten eine schwere Mitralklappeninsuffizienz und bei 1.9% der 
Patienten pulmonale Hypertonie festgestellt. 
- Postoperative Herzkatheteruntersuchungen wurden nur bei wenigen Kindern 
durchgeführt (meist wegen einer pulmonalen Hypertonie). 
Es können aufgrund dieser Ergebnisse folgende Schlussfolgerungen gezogen werden: 
- Die biventriculäre AVSD- Korrektur kann mit guten Langzeitergebnissen und 
einem niedriegem Mortalitätrisiko durchgeführt werden, und wird üblicherweise 
als primäre Korrektur angestrebt. 
- Das Alter zum Zeitpunkt der operativen Behandlung sollte möglichst früh gewählt 
werden, besonders bei Patienten mit Down Syndrom. 
- Das Down Syndrom ist keine Kontraindikation für eine chirurgische Korrektur. 
- Auf eine präoperative Herzkatheteruntersuchung kann bei ausreichender 
echokardiographischer Darstellung des Herzfehlers verzichtet werden. 
- Die länge Bypassdauer and Ischämiezeiten sind nicht mit einer erhöhten 
Morbidität oder Mortalität assoziiert. 
- Unserer Meinung nach bestätigen die sehr guten Langzeitergebnisse, dass die 
AVSD Korrektur sowohl bei Patienten mit Down Syndrom als auch bei nicht- 
syndromalen Patienten mit einem geringen Morbiditäts- und Mortalitätsrisiko 
durchführbar ist.      
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    8. Abbreviations 
     ACE-I                          Angiotensin converting enzyme inhibitors 
    ASD                            Atrial septal defect 
     AV                               Atrioventricular 
     AVSD                          Atrioventricular septal defect 
     cAVSD                        Complete atrioventricular septal defect 
     CPB                             Cardiopulmonary bypass 
     D                                  Down syndrome 
     ECC                             Extracorporeal circulation 
     ECG                             Electrocardiography 
     ECHO                          Echocardiography 
     HLM                            Heart lung machine 
     ICU                              Intensive care unit 
     i.e.,                               That is to say 
     IVC                              Inferior vena cava 
     JET                              Junctional ectopic tachycardia 
     Kg                                Kilogramm 
     LIL                              Left inferior leaflet 
    LLL                             Left lateral leaflet 
     LSL                              Left superior leaflet 
     LVOTO                       Left ventricular outflow tract obstruction 
     LV                                Left ventricle 
     m.                                 Month 
     MI                                Mitral insufficiency 
     min.                              Minute 
     MV                               Mitral valve 
     NYHA                          New York Heart Association 
     ND                               Non- Down syndrome 
     p                                   Probability 
     PA                                Pulmonary artery 
     PAP                              Pulmonary artery pressure 
     pAVSD                        Partial atrioventricular septal defect 
     PDA                             Patent ductus arteriosus 
     PFO                              Patent foramen ovale 
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     PLSVC                         Persistent left superior vena cava 
     RBBB                           Right bundle branch block 
     RIL                               Right inferior leaflet 
     RLL                              Right lateral leaflet 
     RSL                              Right superior leaflet 
     RVOTO                        Right ventricular outflow tract obstruction 
     RV                                Right ventricle 
     SD                                 Standard deviation 
     SVC                              Superior vena cava 
     SVES                            Supraventricular extrasystole 
     SVT                              Supraventricular tachycardia 
     TI                                  Tricuspid insufficiency 
     TV                                Tricuspid valve 
     VES                              Ventricular extrasystole 
     VSD                              Ventricular septal defect 
     VT                                 Ventricular tachycardia 
      y                                    year 
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